organization · Reporting owner
Venrock Partners, L.P.
Disclosed activity across 2 companies
Sign in to followReported relationships
Latest disclosed role at each company.
No relationships currently tracked through insider filings.
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
No balances currently tracked through insider filings.
Past disclosures · reporting ended (2)
No longer tracked through insider filings. These historical balances do not imply present ownership or a zero position.
Bellerophon Therapeutics, Inc.
Report date October 24, 2019 · Filed October 28, 2019
Jointly reported with VENROCK ASSOCIATES IV L P, VENROCK ENTREPRENEURS FUND IV L P, VEF Management IV, LLC, Koh Bong Y, Venrock Healthcare Capital Partners II, L.P., Venrock Management IV, LLC, Venrock Partners Management, LLC, VHCP Co-Investment Holdings II, LLC, VHCP Management II, LLC
Section 16 reporting ended · disclosed 2019-10-28. Current position is not established by this disclosure.
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | IndirectBy funds | 6,435,173 |
Last balance in matching sequence
After 2019-10-28 transaction · row 3
Source-order balances reconcile. Account continuity and personal attribution are not independently verified.
3 source rowsRow 1 · 2019-10-24 · Sale · Disposed 704,595 · Balance 6,824,425 F1: This Form 4 is the first of two Form 4s being filed to report the beneficial ownership of the following Reporting Persons: Venrock Associates IV, LP, Venrock Partners, LP, Venrock Entrepreneurs Fund IV, LP, Venrock Management IV, LLC, Venrock Partners Management, LLC, VEF Management IV, LLC, Venrock Healthcare Capital Partners II, LP, VHCP Management II, LLC, VHCP Co Investment Holdings II, LLC, Venrock Healthcare Capital Partners III, LP, VHCP Management III, LLC, VHCP Co Investment Holdings III, LLC, Bong Koh and Nimish Shah. Two Form 4s are being filed because each form can report a maximum of 10 reporting persons. F2: Consists of: 316,797 shares sold by Venrock Healthcare Capital Partners II, LP, 128,431 shares sold by VHCP Co-Investment Holdings II, LLC, 235,791 shares sold by Venrock Healthcare Capital Partners III, LP and 23,576 shares sold by VHCP Co-Investment Holdings III, LLC. F3: The price in Column 4 is a weighted average price. These shares were sold in multiple transactions a prices within a range of $1.00. The Reporting Persons undertake to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within this range. F4: Venrock Management IV, LLC ("VM4") is the general partner of Venrock Associates IV, LP. Venrock Partners Management, LLC ("VPM") is the general partner of Venrock Partners, LP. VEF Management IV, LLC ("VEFM") is the general partner of Venrock Entrepreneurs Fund IV, LP. VHCP Management II, LLC ("VHCPM2") is the general partner of Venrock Healthcare Capital Partners II, LP and the manager of VHCP Co-Investment Holdings II, LLC. VHCP Management III, LLC ("VHCPM3") is the general partner of Venrock Healthcare Capital Partners III, LP and the manager of VHCP Co-Investment Holdings III, LLC. Bong Koh and Nimish Shah are the managing members of VHCPM2 and VHCPM3. Each of VM4, VPM, VEFM, VHCPM2, VHCPM3, Bong Koh and Nimish Shah (together, the "Managers") may be deemed to beneficially own these shares. Each of the Managers expressly disclaims beneficial ownership over these shares except to the extent of their indirect pecuniary interests therein. Row 2 · 2019-10-25 · Sale · Disposed 56,242 · Balance 6,768,183 F1: This Form 4 is the first of two Form 4s being filed to report the beneficial ownership of the following Reporting Persons: Venrock Associates IV, LP, Venrock Partners, LP, Venrock Entrepreneurs Fund IV, LP, Venrock Management IV, LLC, Venrock Partners Management, LLC, VEF Management IV, LLC, Venrock Healthcare Capital Partners II, LP, VHCP Management II, LLC, VHCP Co Investment Holdings II, LLC, Venrock Healthcare Capital Partners III, LP, VHCP Management III, LLC, VHCP Co Investment Holdings III, LLC, Bong Koh and Nimish Shah. Two Form 4s are being filed because each form can report a maximum of 10 reporting persons. F5: Consists of: 25,287 shares sold by Venrock Healthcare Capital Partners II, LP, 10,252 shares sold by VHCP Co-Investment Holdings II, LLC, 18,821 shares sold by Venrock Healthcare Capital Partners III, LP and 1,882 shares sold by VHCP Co-Investment Holdings III, LLC. F3: The price in Column 4 is a weighted average price. These shares were sold in multiple transactions a prices within a range of $1.00. The Reporting Persons undertake to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within this range. F4: Venrock Management IV, LLC ("VM4") is the general partner of Venrock Associates IV, LP. Venrock Partners Management, LLC ("VPM") is the general partner of Venrock Partners, LP. VEF Management IV, LLC ("VEFM") is the general partner of Venrock Entrepreneurs Fund IV, LP. VHCP Management II, LLC ("VHCPM2") is the general partner of Venrock Healthcare Capital Partners II, LP and the manager of VHCP Co-Investment Holdings II, LLC. VHCP Management III, LLC ("VHCPM3") is the general partner of Venrock Healthcare Capital Partners III, LP and the manager of VHCP Co-Investment Holdings III, LLC. Bong Koh and Nimish Shah are the managing members of VHCPM2 and VHCPM3. Each of VM4, VPM, VEFM, VHCPM2, VHCPM3, Bong Koh and Nimish Shah (together, the "Managers") may be deemed to beneficially own these shares. Each of the Managers expressly disclaims beneficial ownership over these shares except to the extent of their indirect pecuniary interests therein. Row 3 · 2019-10-28 · Sale · Disposed 333,010 · Balance 6,435,173 F1: This Form 4 is the first of two Form 4s being filed to report the beneficial ownership of the following Reporting Persons: Venrock Associates IV, LP, Venrock Partners, LP, Venrock Entrepreneurs Fund IV, LP, Venrock Management IV, LLC, Venrock Partners Management, LLC, VEF Management IV, LLC, Venrock Healthcare Capital Partners II, LP, VHCP Management II, LLC, VHCP Co Investment Holdings II, LLC, Venrock Healthcare Capital Partners III, LP, VHCP Management III, LLC, VHCP Co Investment Holdings III, LLC, Bong Koh and Nimish Shah. Two Form 4s are being filed because each form can report a maximum of 10 reporting persons. F6: Consists of: 149,726 shares sold by Venrock Healthcare Capital Partners II, LP, 60,700 shares sold by VHCP Co-Investment Holdings II, LLC, 111,441 shares sold by Venrock Healthcare Capital Partners III, LP and 11,143 shares sold by VHCP Co-Investment Holdings III, LLC. F3: The price in Column 4 is a weighted average price. These shares were sold in multiple transactions a prices within a range of $1.00. The Reporting Persons undertake to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within this range. F4: Venrock Management IV, LLC ("VM4") is the general partner of Venrock Associates IV, LP. Venrock Partners Management, LLC ("VPM") is the general partner of Venrock Partners, LP. VEF Management IV, LLC ("VEFM") is the general partner of Venrock Entrepreneurs Fund IV, LP. VHCP Management II, LLC ("VHCPM2") is the general partner of Venrock Healthcare Capital Partners II, LP and the manager of VHCP Co-Investment Holdings II, LLC. VHCP Management III, LLC ("VHCPM3") is the general partner of Venrock Healthcare Capital Partners III, LP and the manager of VHCP Co-Investment Holdings III, LLC. Bong Koh and Nimish Shah are the managing members of VHCPM2 and VHCPM3. Each of VM4, VPM, VEFM, VHCPM2, VHCPM3, Bong Koh and Nimish Shah (together, the "Managers") may be deemed to beneficially own these shares. Each of the Managers expressly disclaims beneficial ownership over these shares except to the extent of their indirect pecuniary interests therein. |
Filing footnotes · ownership attribution and instrument terms
F1: This Form 4 is the first of two Form 4s being filed to report the beneficial ownership of the following Reporting Persons: Venrock Associates IV, LP, Venrock Partners, LP, Venrock Entrepreneurs Fund IV, LP, Venrock Management IV, LLC, Venrock Partners Management, LLC, VEF Management IV, LLC, Venrock Healthcare Capital Partners II, LP, VHCP Management II, LLC, VHCP Co Investment Holdings II, LLC, Venrock Healthcare Capital Partners III, LP, VHCP Management III, LLC, VHCP Co Investment Holdings III, LLC, Bong Koh and Nimish Shah. Two Form 4s are being filed because each form can report a maximum of 10 reporting persons.
F2: Consists of: 316,797 shares sold by Venrock Healthcare Capital Partners II, LP, 128,431 shares sold by VHCP Co-Investment Holdings II, LLC, 235,791 shares sold by Venrock Healthcare Capital Partners III, LP and 23,576 shares sold by VHCP Co-Investment Holdings III, LLC.
F3: The price in Column 4 is a weighted average price. These shares were sold in multiple transactions a prices within a range of $1.00. The Reporting Persons undertake to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within this range.
F4: Venrock Management IV, LLC ("VM4") is the general partner of Venrock Associates IV, LP. Venrock Partners Management, LLC ("VPM") is the general partner of Venrock Partners, LP. VEF Management IV, LLC ("VEFM") is the general partner of Venrock Entrepreneurs Fund IV, LP. VHCP Management II, LLC ("VHCPM2") is the general partner of Venrock Healthcare Capital Partners II, LP and the manager of VHCP Co-Investment Holdings II, LLC. VHCP Management III, LLC ("VHCPM3") is the general partner of Venrock Healthcare Capital Partners III, LP and the manager of VHCP Co-Investment Holdings III, LLC. Bong Koh and Nimish Shah are the managing members of VHCPM2 and VHCPM3. Each of VM4, VPM, VEFM, VHCPM2, VHCPM3, Bong Koh and Nimish Shah (together, the "Managers") may be deemed to beneficially own these shares. Each of the Managers expressly disclaims beneficial ownership over these shares except to the extent of their indirect pecuniary interests therein.
F5: Consists of: 25,287 shares sold by Venrock Healthcare Capital Partners II, LP, 10,252 shares sold by VHCP Co-Investment Holdings II, LLC, 18,821 shares sold by Venrock Healthcare Capital Partners III, LP and 1,882 shares sold by VHCP Co-Investment Holdings III, LLC.
F6: Consists of: 149,726 shares sold by Venrock Healthcare Capital Partners II, LP, 60,700 shares sold by VHCP Co-Investment Holdings II, LLC, 111,441 shares sold by Venrock Healthcare Capital Partners III, LP and 11,143 shares sold by VHCP Co-Investment Holdings III, LLC.
ON Semiconductor Connectivity Solutions, Inc.
Report date November 02, 2016 · Filed November 04, 2016
Jointly reported with VENROCK ASSOCIATES IV L P, VENROCK ENTREPRENEURS FUND IV L P, Venrock Management IV, LLC, Venrock Partners Management, LLC, VEF Management IV, LLC
Section 16 reporting ended · disclosed 2016-11-04. Current position is not established by this disclosure.
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | IndirectSee footnote | 608,340 |
Reported balance
After 2016-11-02 transaction · row 1
Joint disclosure: continuity of the reported position is unresolved; see ownership footnotes.
1 source rowRow 1 · 2016-11-02 · Conversion · Acquired 608,340 · Balance 608,340 F1: The Series A Preferred Stock automatically converted into Common Stock on a 1.8868501529052:1 basis immediately prior to the closing of the Issuer's initial public offering and had no expiration date. F2: The Series B Preferred Stock automatically converted into Common Stock on a 1.9332015399022:1 basis immediately prior to the closing of the Issuer's initial public offering and had no expiration date. F3: The Series C Preferred Stock automatically converted into Common Stock on a 1.97882655585238:1 basis immediately prior to the closing of the Issuer's initial public offering and had no expiration date. F4: The Series D Preferred Stock automatically converted into Common Stock on a 1:1 basis immediately prior to the closing of the Issuer's initial public offering and had no expiration date. F5: The Series E Preferred Stock automatically converted into Common Stock on a 1:1 basis immediately prior to the closing of the Issuer's initial public offering and had no expiration date. F6: The Series F-1 Preferred Stock automatically converted into Common Stock on a 1:1 basis immediately prior to the closing of the Issuer's initial public offering and had no expiration date. F7: The Series G Preferred Stock automatically converted into Common Stock on a 1:1 basis immediately prior to the closing of the Issuer's initial public offering and had no expiration date. F8: Consists of an aggregate of 495,190 shares of Common Stock held by Venrock Associates IV, L.P. ("Venrock IV"), 100,984 shares of Common Stock held by Venrock Partners, L.P. ("Venrock Partners"), and 12,166 shares of Common Stock held by Venrock Entrepreneurs Fund IV,L.P. ("Venrock Entrepreneurs" and together with Venrock IV and Venrock Partners, the "Venrock Entities"). VM4, VPM and VEFM4 disclaim beneficial ownership over all shares held by Venrock IV, Venrock Partners and Venrock Entrepreneurs, except to the extent of their indirect pecuniary interests therein. |
| Common StockSEC Table I · non-derivative | IndirectSee footnote | 747,036 |
Reported balance
After 2016-11-02 transaction · row 2
Joint disclosure: continuity of the reported position is unresolved; see ownership footnotes.
1 source rowRow 2 · 2016-11-02 · Conversion · Acquired 138,696 · Balance 747,036 F1: The Series A Preferred Stock automatically converted into Common Stock on a 1.8868501529052:1 basis immediately prior to the closing of the Issuer's initial public offering and had no expiration date. F2: The Series B Preferred Stock automatically converted into Common Stock on a 1.9332015399022:1 basis immediately prior to the closing of the Issuer's initial public offering and had no expiration date. F3: The Series C Preferred Stock automatically converted into Common Stock on a 1.97882655585238:1 basis immediately prior to the closing of the Issuer's initial public offering and had no expiration date. F4: The Series D Preferred Stock automatically converted into Common Stock on a 1:1 basis immediately prior to the closing of the Issuer's initial public offering and had no expiration date. F5: The Series E Preferred Stock automatically converted into Common Stock on a 1:1 basis immediately prior to the closing of the Issuer's initial public offering and had no expiration date. F6: The Series F-1 Preferred Stock automatically converted into Common Stock on a 1:1 basis immediately prior to the closing of the Issuer's initial public offering and had no expiration date. F7: The Series G Preferred Stock automatically converted into Common Stock on a 1:1 basis immediately prior to the closing of the Issuer's initial public offering and had no expiration date. F9: Consists of an aggregate of 608,091 shares of Common Stock held by Venrock IV, 124,007 shares of Common Stock held by Venrock Partners, and 14,938 shares of Common Stock held by Venrock Entrepreneurs. VM4, VPM and VEFM4 disclaim beneficial ownership over all shares held by Venrock IV, Venrock Partners and Venrock Entrepreneurs, except to the extent of their indirect pecuniary interests therein. |
| Common StockSEC Table I · non-derivative | IndirectSee footnote | 933,680 |
Reported balance
After 2016-11-02 transaction · row 3
Joint disclosure: continuity of the reported position is unresolved; see ownership footnotes.
1 source rowRow 3 · 2016-11-02 · Conversion · Acquired 186,644 · Balance 933,680 F1: The Series A Preferred Stock automatically converted into Common Stock on a 1.8868501529052:1 basis immediately prior to the closing of the Issuer's initial public offering and had no expiration date. F2: The Series B Preferred Stock automatically converted into Common Stock on a 1.9332015399022:1 basis immediately prior to the closing of the Issuer's initial public offering and had no expiration date. F3: The Series C Preferred Stock automatically converted into Common Stock on a 1.97882655585238:1 basis immediately prior to the closing of the Issuer's initial public offering and had no expiration date. F4: The Series D Preferred Stock automatically converted into Common Stock on a 1:1 basis immediately prior to the closing of the Issuer's initial public offering and had no expiration date. F5: The Series E Preferred Stock automatically converted into Common Stock on a 1:1 basis immediately prior to the closing of the Issuer's initial public offering and had no expiration date. F6: The Series F-1 Preferred Stock automatically converted into Common Stock on a 1:1 basis immediately prior to the closing of the Issuer's initial public offering and had no expiration date. F7: The Series G Preferred Stock automatically converted into Common Stock on a 1:1 basis immediately prior to the closing of the Issuer's initial public offering and had no expiration date. F10: Consists of an aggregate of 760,021 shares of Common Stock held by Venrock IV, 154,989 shares of Common Stock held by Venrock Partners, and 18,670 shares of Common Stock held by Venrock Entrepreneurs. VM4, VPM and VEFM4 disclaim beneficial ownership over all shares held by Venrock IV, Venrock Partners and Venrock Entrepreneurs, except to the extent of their indirect pecuniary interests therein. |
| Common StockSEC Table I · non-derivative | IndirectSee footnote | 1,739,305 |
Reported balance
After 2016-11-02 transaction · row 4
Joint disclosure: continuity of the reported position is unresolved; see ownership footnotes.
1 source rowRow 4 · 2016-11-02 · Conversion · Acquired 805,625 · Balance 1,739,305 F1: The Series A Preferred Stock automatically converted into Common Stock on a 1.8868501529052:1 basis immediately prior to the closing of the Issuer's initial public offering and had no expiration date. F2: The Series B Preferred Stock automatically converted into Common Stock on a 1.9332015399022:1 basis immediately prior to the closing of the Issuer's initial public offering and had no expiration date. F3: The Series C Preferred Stock automatically converted into Common Stock on a 1.97882655585238:1 basis immediately prior to the closing of the Issuer's initial public offering and had no expiration date. F4: The Series D Preferred Stock automatically converted into Common Stock on a 1:1 basis immediately prior to the closing of the Issuer's initial public offering and had no expiration date. F5: The Series E Preferred Stock automatically converted into Common Stock on a 1:1 basis immediately prior to the closing of the Issuer's initial public offering and had no expiration date. F6: The Series F-1 Preferred Stock automatically converted into Common Stock on a 1:1 basis immediately prior to the closing of the Issuer's initial public offering and had no expiration date. F7: The Series G Preferred Stock automatically converted into Common Stock on a 1:1 basis immediately prior to the closing of the Issuer's initial public offering and had no expiration date. F11: Consists of an aggregate of 1,415,801 shares of Common Stock held by Venrock IV, 288,723 shares of Common Stock held by Venrock Partners, and 34,781 shares of Common Stock held by Venrock Entrepreneurs. VM4, VPM and VEFM4 disclaim beneficial ownership over all shares held by Venrock IV, Venrock Partners and Venrock Entrepreneurs, except to the extent of their indirect pecuniary interests therein. |
| Common StockSEC Table I · non-derivative | IndirectSee footnote | 2,209,084 |
Reported balance
After 2016-11-02 transaction · row 5
Joint disclosure: continuity of the reported position is unresolved; see ownership footnotes.
1 source rowRow 5 · 2016-11-02 · Conversion · Acquired 469,779 · Balance 2,209,084 F1: The Series A Preferred Stock automatically converted into Common Stock on a 1.8868501529052:1 basis immediately prior to the closing of the Issuer's initial public offering and had no expiration date. F2: The Series B Preferred Stock automatically converted into Common Stock on a 1.9332015399022:1 basis immediately prior to the closing of the Issuer's initial public offering and had no expiration date. F3: The Series C Preferred Stock automatically converted into Common Stock on a 1.97882655585238:1 basis immediately prior to the closing of the Issuer's initial public offering and had no expiration date. F4: The Series D Preferred Stock automatically converted into Common Stock on a 1:1 basis immediately prior to the closing of the Issuer's initial public offering and had no expiration date. F5: The Series E Preferred Stock automatically converted into Common Stock on a 1:1 basis immediately prior to the closing of the Issuer's initial public offering and had no expiration date. F6: The Series F-1 Preferred Stock automatically converted into Common Stock on a 1:1 basis immediately prior to the closing of the Issuer's initial public offering and had no expiration date. F7: The Series G Preferred Stock automatically converted into Common Stock on a 1:1 basis immediately prior to the closing of the Issuer's initial public offering and had no expiration date. F12: Consists of an aggregate of 1,798,202 shares of Common Stock held by Venrock IV, 366,706 shares of Common Stock held by Venrock Partners, and 44,176 shares of Common Stock held by Venrock Entrepreneurs. VM4, VPM and VEFM4 disclaim beneficial ownership over all shares held by Venrock IV, Venrock Partners and Venrock Entrepreneurs, except to the extent of their indirect pecuniary interests therein. |
| Common StockSEC Table I · non-derivative | IndirectSee footnote | 2,592,718 |
Reported balance
After 2016-11-02 transaction · row 6
Joint disclosure: continuity of the reported position is unresolved; see ownership footnotes.
1 source rowRow 6 · 2016-11-02 · Conversion · Acquired 383,634 · Balance 2,592,718 F1: The Series A Preferred Stock automatically converted into Common Stock on a 1.8868501529052:1 basis immediately prior to the closing of the Issuer's initial public offering and had no expiration date. F2: The Series B Preferred Stock automatically converted into Common Stock on a 1.9332015399022:1 basis immediately prior to the closing of the Issuer's initial public offering and had no expiration date. F3: The Series C Preferred Stock automatically converted into Common Stock on a 1.97882655585238:1 basis immediately prior to the closing of the Issuer's initial public offering and had no expiration date. F4: The Series D Preferred Stock automatically converted into Common Stock on a 1:1 basis immediately prior to the closing of the Issuer's initial public offering and had no expiration date. F5: The Series E Preferred Stock automatically converted into Common Stock on a 1:1 basis immediately prior to the closing of the Issuer's initial public offering and had no expiration date. F6: The Series F-1 Preferred Stock automatically converted into Common Stock on a 1:1 basis immediately prior to the closing of the Issuer's initial public offering and had no expiration date. F7: The Series G Preferred Stock automatically converted into Common Stock on a 1:1 basis immediately prior to the closing of the Issuer's initial public offering and had no expiration date. F13: Consists of an aggregate of 2,110,481 shares of Common Stock held by Venrock IV, 430,389 shares of Common Stock held by Venrock Partners, and 51,848 shares of Common Stock held by Venrock Entrepreneurs. VM4, VPM and VEFM4 disclaim beneficial ownership over all shares held by Venrock IV, Venrock Partners and Venrock Entrepreneurs, except to the extent of their indirect pecuniary interests therein. |
| Common StockSEC Table I · non-derivative | IndirectSee footnote | 2,653,269 |
Reported balance
After 2016-11-02 transaction · row 7
Joint disclosure: continuity of the reported position is unresolved; see ownership footnotes.
1 source rowRow 7 · 2016-11-02 · Conversion · Acquired 60,551 · Balance 2,653,269 F1: The Series A Preferred Stock automatically converted into Common Stock on a 1.8868501529052:1 basis immediately prior to the closing of the Issuer's initial public offering and had no expiration date. F2: The Series B Preferred Stock automatically converted into Common Stock on a 1.9332015399022:1 basis immediately prior to the closing of the Issuer's initial public offering and had no expiration date. F3: The Series C Preferred Stock automatically converted into Common Stock on a 1.97882655585238:1 basis immediately prior to the closing of the Issuer's initial public offering and had no expiration date. F4: The Series D Preferred Stock automatically converted into Common Stock on a 1:1 basis immediately prior to the closing of the Issuer's initial public offering and had no expiration date. F5: The Series E Preferred Stock automatically converted into Common Stock on a 1:1 basis immediately prior to the closing of the Issuer's initial public offering and had no expiration date. F6: The Series F-1 Preferred Stock automatically converted into Common Stock on a 1:1 basis immediately prior to the closing of the Issuer's initial public offering and had no expiration date. F7: The Series G Preferred Stock automatically converted into Common Stock on a 1:1 basis immediately prior to the closing of the Issuer's initial public offering and had no expiration date. F14: Consists of an aggregate of 2,159,770 shares of Common Stock held by Venrock IV, 440,440 shares of Common Stock held by Venrock Partners, and 53,059 shares of Common Stock held by Venrock Entrepreneurs. VM4, VPM and VEFM4 disclaim beneficial ownership over all shares held by Venrock IV, Venrock Partners and Venrock Entrepreneurs, except to the extent of their indirect pecuniary interests therein. |
| Series A Preferred StockSEC Table II · derivative / convertible security | IndirectSee footnote | 0 |
Reported balance
After 2016-11-02 transaction · row 8
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 8 · 2016-11-02 · Conversion · Disposed 322,411 · Balance 0 F1: The Series A Preferred Stock automatically converted into Common Stock on a 1.8868501529052:1 basis immediately prior to the closing of the Issuer's initial public offering and had no expiration date. F15: Consisted of an aggregate of 262,443 shares of Series A Preferred Stock held by Venrock IV, 53,520 shares of Series A Preferred Stock held by Venrock Partners, and 6,448 shares of Series A Preferred Stock held by Venrock Entrepreneurs. VM4, VPM and VEFM4 disclaim beneficial ownership over all shares held by Venrock IV, Venrock Partners and Venrock Entrepreneurs, except to the extent of their indirect pecuniary interests therein. F16: The sole general partner of Venrock IV is Venrock Management IV, LLC ("VM4"). The sole general partner of Venrock Partners is Venrock Partners Management, LLC ("VPM"). The sole general partner of Venrock Entrepreneurs is VEF Management IV, LLC ("VEFM4"). |
| Series B Preferred StockSEC Table II · derivative / convertible security | IndirectSee footnote | 0 |
Reported balance
After 2016-11-02 transaction · row 9
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 9 · 2016-11-02 · Conversion · Disposed 71,744 · Balance 0 F2: The Series B Preferred Stock automatically converted into Common Stock on a 1.9332015399022:1 basis immediately prior to the closing of the Issuer's initial public offering and had no expiration date. F17: Consisted of an aggregate of 58,401 shares of Series B Preferred Stock held by Venrock IV, 11,909 shares of Series B Preferred Stock held by Venrock Partners, and 1,434 shares of Series B Preferred Stock held by Venrock Entrepreneurs. VM4, VPM and VEFM4 disclaim beneficial ownership over all shares held by Venrock IV, Venrock Partners and Venrock Entrepreneurs, except to the extent of their indirect pecuniary interests therein. F16: The sole general partner of Venrock IV is Venrock Management IV, LLC ("VM4"). The sole general partner of Venrock Partners is Venrock Partners Management, LLC ("VPM"). The sole general partner of Venrock Entrepreneurs is VEF Management IV, LLC ("VEFM4"). |
| Series C Preferred StockSEC Table II · derivative / convertible security | IndirectSee footnote | 0 |
Reported balance
After 2016-11-02 transaction · row 10
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 10 · 2016-11-02 · Conversion · Disposed 94,321 · Balance 0 F3: The Series C Preferred Stock automatically converted into Common Stock on a 1.97882655585238:1 basis immediately prior to the closing of the Issuer's initial public offering and had no expiration date. F18: Consisted of an aggregate of 76,778 shares of Series C Preferred Stock held by Venrock IV, 15,657 shares of Series C Preferred Stock held by Venrock Partners, and 1,886 shares of Series C Preferred Stock held by Venrock Entrepreneurs. VM4, VPM and VEFM4 disclaim beneficial ownership over all shares held by Venrock IV, Venrock Partners and Venrock Entrepreneurs, except to the extent of their indirect pecuniary interests therein. F16: The sole general partner of Venrock IV is Venrock Management IV, LLC ("VM4"). The sole general partner of Venrock Partners is Venrock Partners Management, LLC ("VPM"). The sole general partner of Venrock Entrepreneurs is VEF Management IV, LLC ("VEFM4"). |
| Series D Preferred StockSEC Table II · derivative / convertible security | IndirectSee footnote | 0 |
Reported balance
After 2016-11-02 transaction · row 11
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 11 · 2016-11-02 · Conversion · Disposed 805,625 · Balance 0 F4: The Series D Preferred Stock automatically converted into Common Stock on a 1:1 basis immediately prior to the closing of the Issuer's initial public offering and had no expiration date. F19: Consisted of an aggregate of 655,780 shares of Series D Preferred Stock held by Venrock IV, 133,734 shares of Series D Preferred Stock held by Venrock Partners, and 16,111 shares of Series D Preferred Stock held by Venrock Entrepreneurs. VM4, VPM and VEFM4 disclaim beneficial ownership over all shares held by Venrock IV, Venrock Partners and Venrock Entrepreneurs, except to the extent of their indirect pecuniary interests therein. F16: The sole general partner of Venrock IV is Venrock Management IV, LLC ("VM4"). The sole general partner of Venrock Partners is Venrock Partners Management, LLC ("VPM"). The sole general partner of Venrock Entrepreneurs is VEF Management IV, LLC ("VEFM4"). |
| Series E Preferred StockSEC Table II · derivative / convertible security | IndirectSee footnote | 0 |
Reported balance
After 2016-11-02 transaction · row 12
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 12 · 2016-11-02 · Conversion · Disposed 469,779 · Balance 0 F5: The Series E Preferred Stock automatically converted into Common Stock on a 1:1 basis immediately prior to the closing of the Issuer's initial public offering and had no expiration date. F20: Consisted of an aggregate of 382,401 shares of Series E Preferred Stock held by Venrock IV, 77,983 shares of Series E Preferred Stock held by Venrock Partners, and 9,395 shares of Series E Preferred Stock held by Venrock Entrepreneurs. VM4, VPM and VEFM4 disclaim beneficial ownership over all shares held by Venrock IV, Venrock Partners and Venrock Entrepreneurs, except to the extent of their indirect pecuniary interests therein. F16: The sole general partner of Venrock IV is Venrock Management IV, LLC ("VM4"). The sole general partner of Venrock Partners is Venrock Partners Management, LLC ("VPM"). The sole general partner of Venrock Entrepreneurs is VEF Management IV, LLC ("VEFM4"). |
| Series F-1 Preferred StockSEC Table II · derivative / convertible security | IndirectSee footnote | 0 |
Reported balance
After 2016-11-02 transaction · row 13
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 13 · 2016-11-02 · Conversion · Disposed 383,634 · Balance 0 F6: The Series F-1 Preferred Stock automatically converted into Common Stock on a 1:1 basis immediately prior to the closing of the Issuer's initial public offering and had no expiration date. F21: Consisted of an aggregate of 312,279 shares of Series F-1 Preferred Stock held by Venrock IV, 63,683 shares of Series F-1 Preferred Stock held by Venrock Partners, and 7,672 shares of Series F-1 Preferred Stock held by Venrock Entrepreneurs. VM4, VPM and VEFM4 disclaim beneficial ownership over all shares held by Venrock IV, Venrock Partners and Venrock Entrepreneurs, except to the extent of their indirect pecuniary interests therein. F16: The sole general partner of Venrock IV is Venrock Management IV, LLC ("VM4"). The sole general partner of Venrock Partners is Venrock Partners Management, LLC ("VPM"). The sole general partner of Venrock Entrepreneurs is VEF Management IV, LLC ("VEFM4"). |
| Series G Preferred StockSEC Table II · derivative / convertible security | IndirectSee footnote | 0 |
Reported balance
After 2016-11-02 transaction · row 14
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 14 · 2016-11-02 · Conversion · Disposed 60,551 · Balance 0 F7: The Series G Preferred Stock automatically converted into Common Stock on a 1:1 basis immediately prior to the closing of the Issuer's initial public offering and had no expiration date. F22: Consisted of an aggregate of 49,289 shares of Series G Preferred Stock held by Venrock IV, 10,051 shares of Series G Preferred Stock held by Venrock Partners, and 1,211 shares of Series G Preferred Stock held by Venrock Entrepreneurs. VM4, VPM and VEFM4 disclaim beneficial ownership over all shares held by Venrock IV, Venrock Partners and Venrock Entrepreneurs, except to the extent of their indirect pecuniary interests therein. F16: The sole general partner of Venrock IV is Venrock Management IV, LLC ("VM4"). The sole general partner of Venrock Partners is Venrock Partners Management, LLC ("VPM"). The sole general partner of Venrock Entrepreneurs is VEF Management IV, LLC ("VEFM4"). |
Filing footnotes · ownership attribution and instrument terms
F1: The Series A Preferred Stock automatically converted into Common Stock on a 1.8868501529052:1 basis immediately prior to the closing of the Issuer's initial public offering and had no expiration date.
F2: The Series B Preferred Stock automatically converted into Common Stock on a 1.9332015399022:1 basis immediately prior to the closing of the Issuer's initial public offering and had no expiration date.
F3: The Series C Preferred Stock automatically converted into Common Stock on a 1.97882655585238:1 basis immediately prior to the closing of the Issuer's initial public offering and had no expiration date.
F4: The Series D Preferred Stock automatically converted into Common Stock on a 1:1 basis immediately prior to the closing of the Issuer's initial public offering and had no expiration date.
F5: The Series E Preferred Stock automatically converted into Common Stock on a 1:1 basis immediately prior to the closing of the Issuer's initial public offering and had no expiration date.
F6: The Series F-1 Preferred Stock automatically converted into Common Stock on a 1:1 basis immediately prior to the closing of the Issuer's initial public offering and had no expiration date.
F7: The Series G Preferred Stock automatically converted into Common Stock on a 1:1 basis immediately prior to the closing of the Issuer's initial public offering and had no expiration date.
F8: Consists of an aggregate of 495,190 shares of Common Stock held by Venrock Associates IV, L.P. ("Venrock IV"), 100,984 shares of Common Stock held by Venrock Partners, L.P. ("Venrock Partners"), and 12,166 shares of Common Stock held by Venrock Entrepreneurs Fund IV,L.P. ("Venrock Entrepreneurs" and together with Venrock IV and Venrock Partners, the "Venrock Entities"). VM4, VPM and VEFM4 disclaim beneficial ownership over all shares held by Venrock IV, Venrock Partners and Venrock Entrepreneurs, except to the extent of their indirect pecuniary interests therein.
F9: Consists of an aggregate of 608,091 shares of Common Stock held by Venrock IV, 124,007 shares of Common Stock held by Venrock Partners, and 14,938 shares of Common Stock held by Venrock Entrepreneurs. VM4, VPM and VEFM4 disclaim beneficial ownership over all shares held by Venrock IV, Venrock Partners and Venrock Entrepreneurs, except to the extent of their indirect pecuniary interests therein.
F10: Consists of an aggregate of 760,021 shares of Common Stock held by Venrock IV, 154,989 shares of Common Stock held by Venrock Partners, and 18,670 shares of Common Stock held by Venrock Entrepreneurs. VM4, VPM and VEFM4 disclaim beneficial ownership over all shares held by Venrock IV, Venrock Partners and Venrock Entrepreneurs, except to the extent of their indirect pecuniary interests therein.
F11: Consists of an aggregate of 1,415,801 shares of Common Stock held by Venrock IV, 288,723 shares of Common Stock held by Venrock Partners, and 34,781 shares of Common Stock held by Venrock Entrepreneurs. VM4, VPM and VEFM4 disclaim beneficial ownership over all shares held by Venrock IV, Venrock Partners and Venrock Entrepreneurs, except to the extent of their indirect pecuniary interests therein.
F12: Consists of an aggregate of 1,798,202 shares of Common Stock held by Venrock IV, 366,706 shares of Common Stock held by Venrock Partners, and 44,176 shares of Common Stock held by Venrock Entrepreneurs. VM4, VPM and VEFM4 disclaim beneficial ownership over all shares held by Venrock IV, Venrock Partners and Venrock Entrepreneurs, except to the extent of their indirect pecuniary interests therein.
F13: Consists of an aggregate of 2,110,481 shares of Common Stock held by Venrock IV, 430,389 shares of Common Stock held by Venrock Partners, and 51,848 shares of Common Stock held by Venrock Entrepreneurs. VM4, VPM and VEFM4 disclaim beneficial ownership over all shares held by Venrock IV, Venrock Partners and Venrock Entrepreneurs, except to the extent of their indirect pecuniary interests therein.
F14: Consists of an aggregate of 2,159,770 shares of Common Stock held by Venrock IV, 440,440 shares of Common Stock held by Venrock Partners, and 53,059 shares of Common Stock held by Venrock Entrepreneurs. VM4, VPM and VEFM4 disclaim beneficial ownership over all shares held by Venrock IV, Venrock Partners and Venrock Entrepreneurs, except to the extent of their indirect pecuniary interests therein.
F15: Consisted of an aggregate of 262,443 shares of Series A Preferred Stock held by Venrock IV, 53,520 shares of Series A Preferred Stock held by Venrock Partners, and 6,448 shares of Series A Preferred Stock held by Venrock Entrepreneurs. VM4, VPM and VEFM4 disclaim beneficial ownership over all shares held by Venrock IV, Venrock Partners and Venrock Entrepreneurs, except to the extent of their indirect pecuniary interests therein.
F16: The sole general partner of Venrock IV is Venrock Management IV, LLC ("VM4"). The sole general partner of Venrock Partners is Venrock Partners Management, LLC ("VPM"). The sole general partner of Venrock Entrepreneurs is VEF Management IV, LLC ("VEFM4").
F17: Consisted of an aggregate of 58,401 shares of Series B Preferred Stock held by Venrock IV, 11,909 shares of Series B Preferred Stock held by Venrock Partners, and 1,434 shares of Series B Preferred Stock held by Venrock Entrepreneurs. VM4, VPM and VEFM4 disclaim beneficial ownership over all shares held by Venrock IV, Venrock Partners and Venrock Entrepreneurs, except to the extent of their indirect pecuniary interests therein.
F18: Consisted of an aggregate of 76,778 shares of Series C Preferred Stock held by Venrock IV, 15,657 shares of Series C Preferred Stock held by Venrock Partners, and 1,886 shares of Series C Preferred Stock held by Venrock Entrepreneurs. VM4, VPM and VEFM4 disclaim beneficial ownership over all shares held by Venrock IV, Venrock Partners and Venrock Entrepreneurs, except to the extent of their indirect pecuniary interests therein.
F19: Consisted of an aggregate of 655,780 shares of Series D Preferred Stock held by Venrock IV, 133,734 shares of Series D Preferred Stock held by Venrock Partners, and 16,111 shares of Series D Preferred Stock held by Venrock Entrepreneurs. VM4, VPM and VEFM4 disclaim beneficial ownership over all shares held by Venrock IV, Venrock Partners and Venrock Entrepreneurs, except to the extent of their indirect pecuniary interests therein.
F20: Consisted of an aggregate of 382,401 shares of Series E Preferred Stock held by Venrock IV, 77,983 shares of Series E Preferred Stock held by Venrock Partners, and 9,395 shares of Series E Preferred Stock held by Venrock Entrepreneurs. VM4, VPM and VEFM4 disclaim beneficial ownership over all shares held by Venrock IV, Venrock Partners and Venrock Entrepreneurs, except to the extent of their indirect pecuniary interests therein.
F21: Consisted of an aggregate of 312,279 shares of Series F-1 Preferred Stock held by Venrock IV, 63,683 shares of Series F-1 Preferred Stock held by Venrock Partners, and 7,672 shares of Series F-1 Preferred Stock held by Venrock Entrepreneurs. VM4, VPM and VEFM4 disclaim beneficial ownership over all shares held by Venrock IV, Venrock Partners and Venrock Entrepreneurs, except to the extent of their indirect pecuniary interests therein.
F22: Consisted of an aggregate of 49,289 shares of Series G Preferred Stock held by Venrock IV, 10,051 shares of Series G Preferred Stock held by Venrock Partners, and 1,211 shares of Series G Preferred Stock held by Venrock Entrepreneurs. VM4, VPM and VEFM4 disclaim beneficial ownership over all shares held by Venrock IV, Venrock Partners and Venrock Entrepreneurs, except to the extent of their indirect pecuniary interests therein.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| October 28, 2019 Filed Oct 28, 2019 17:15 UTC | Bellerophon Therapeutics, Inc. BLPH · Entity 108982 | SaleCommon Stock | 333,010 | $0.44 | $146,091.49 |
DisclosureSEC source: 0001209191-19-054264 · doc4.xml · nonDerivative · entry 3 VENROCK ASSOCIATES IV L P · CIK 0001277997 · 10% owner VENROCK ENTREPRENEURS FUND IV L P · CIK 0001277994 · 10% owner VEF Management IV, LLC · CIK 0001305243 · 10% owner Koh Bong Y · CIK 0001615979 · 10% owner Venrock Healthcare Capital Partners II, L.P. · CIK 0001602264 · 10% owner Venrock Management IV, LLC · CIK 0001305238 · 10% owner Venrock Partners Management, LLC · CIK 0001305240 · 10% owner Venrock Partners, L.P. · CIK 0001305239 · 10% owner VHCP Co-Investment Holdings II, LLC · CIK 0001615983 · 10% owner VHCP Management II, LLC · CIK 0001602263 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · By funds Disclosed balance after: 6,435,173 F1 · date: This Form 4 is the first of two Form 4s being filed to report the beneficial ownership of the following Reporting Persons: Venrock Associates IV, LP, Venrock Partners, LP, Venrock Entrepreneurs Fund IV, LP, Venrock Management IV, LLC, Venrock Partners Management, LLC, VEF Management IV, LLC, Venrock Healthcare Capital Partners II, LP, VHCP Management II, LLC, VHCP Co Investment Holdings II, LLC, Venrock Healthcare Capital Partners III, LP, VHCP Management III, LLC, VHCP Co Investment Holdings III, LLC, Bong Koh and Nimish Shah. Two Form 4s are being filed because each form can report a maximum of 10 reporting persons. F6 · shares: Consists of: 149,726 shares sold by Venrock Healthcare Capital Partners II, LP, 60,700 shares sold by VHCP Co-Investment Holdings II, LLC, 111,441 shares sold by Venrock Healthcare Capital Partners III, LP and 11,143 shares sold by VHCP Co-Investment Holdings III, LLC. F3 · price: The price in Column 4 is a weighted average price. These shares were sold in multiple transactions a prices within a range of $1.00. The Reporting Persons undertake to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within this range. F4 · ownership.nature: Venrock Management IV, LLC ("VM4") is the general partner of Venrock Associates IV, LP. Venrock Partners Management, LLC ("VPM") is the general partner of Venrock Partners, LP. VEF Management IV, LLC ("VEFM") is the general partner of Venrock Entrepreneurs Fund IV, LP. VHCP Management II, LLC ("VHCPM2") is the general partner of Venrock Healthcare Capital Partners II, LP and the manager of VHCP Co-Investment Holdings II, LLC. VHCP Management III, LLC ("VHCPM3") is the general partner of Venrock Healthcare Capital Partners III, LP and the manager of VHCP Co-Investment Holdings III, LLC. Bong Koh and Nimish Shah are the managing members of VHCPM2 and VHCPM3. Each of VM4, VPM, VEFM, VHCPM2, VHCPM3, Bong Koh and Nimish Shah (together, the "Managers") may be deemed to beneficially own these shares. Each of the Managers expressly disclaims beneficial ownership over these shares except to the extent of their indirect pecuniary interests therein. Read SEC document |
| October 25, 2019 Filed Oct 28, 2019 17:15 UTC | Bellerophon Therapeutics, Inc. BLPH · Entity 108982 | SaleCommon Stock | 56,242 | $0.45 | $25,511.37 |
DisclosureSEC source: 0001209191-19-054264 · doc4.xml · nonDerivative · entry 2 VENROCK ASSOCIATES IV L P · CIK 0001277997 · 10% owner VENROCK ENTREPRENEURS FUND IV L P · CIK 0001277994 · 10% owner VEF Management IV, LLC · CIK 0001305243 · 10% owner Koh Bong Y · CIK 0001615979 · 10% owner Venrock Healthcare Capital Partners II, L.P. · CIK 0001602264 · 10% owner Venrock Management IV, LLC · CIK 0001305238 · 10% owner Venrock Partners Management, LLC · CIK 0001305240 · 10% owner Venrock Partners, L.P. · CIK 0001305239 · 10% owner VHCP Co-Investment Holdings II, LLC · CIK 0001615983 · 10% owner VHCP Management II, LLC · CIK 0001602263 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · By funds Disclosed balance after: 6,768,183 F1 · date: This Form 4 is the first of two Form 4s being filed to report the beneficial ownership of the following Reporting Persons: Venrock Associates IV, LP, Venrock Partners, LP, Venrock Entrepreneurs Fund IV, LP, Venrock Management IV, LLC, Venrock Partners Management, LLC, VEF Management IV, LLC, Venrock Healthcare Capital Partners II, LP, VHCP Management II, LLC, VHCP Co Investment Holdings II, LLC, Venrock Healthcare Capital Partners III, LP, VHCP Management III, LLC, VHCP Co Investment Holdings III, LLC, Bong Koh and Nimish Shah. Two Form 4s are being filed because each form can report a maximum of 10 reporting persons. F5 · shares: Consists of: 25,287 shares sold by Venrock Healthcare Capital Partners II, LP, 10,252 shares sold by VHCP Co-Investment Holdings II, LLC, 18,821 shares sold by Venrock Healthcare Capital Partners III, LP and 1,882 shares sold by VHCP Co-Investment Holdings III, LLC. F3 · price: The price in Column 4 is a weighted average price. These shares were sold in multiple transactions a prices within a range of $1.00. The Reporting Persons undertake to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within this range. F4 · ownership.nature: Venrock Management IV, LLC ("VM4") is the general partner of Venrock Associates IV, LP. Venrock Partners Management, LLC ("VPM") is the general partner of Venrock Partners, LP. VEF Management IV, LLC ("VEFM") is the general partner of Venrock Entrepreneurs Fund IV, LP. VHCP Management II, LLC ("VHCPM2") is the general partner of Venrock Healthcare Capital Partners II, LP and the manager of VHCP Co-Investment Holdings II, LLC. VHCP Management III, LLC ("VHCPM3") is the general partner of Venrock Healthcare Capital Partners III, LP and the manager of VHCP Co-Investment Holdings III, LLC. Bong Koh and Nimish Shah are the managing members of VHCPM2 and VHCPM3. Each of VM4, VPM, VEFM, VHCPM2, VHCPM3, Bong Koh and Nimish Shah (together, the "Managers") may be deemed to beneficially own these shares. Each of the Managers expressly disclaims beneficial ownership over these shares except to the extent of their indirect pecuniary interests therein. Read SEC document |
| October 24, 2019 Filed Oct 28, 2019 17:15 UTC | Bellerophon Therapeutics, Inc. BLPH · Entity 108982 | SaleCommon Stock | 704,595 | $0.50 | $353,354.39 |
DisclosureSEC source: 0001209191-19-054264 · doc4.xml · nonDerivative · entry 1 VENROCK ASSOCIATES IV L P · CIK 0001277997 · 10% owner VENROCK ENTREPRENEURS FUND IV L P · CIK 0001277994 · 10% owner VEF Management IV, LLC · CIK 0001305243 · 10% owner Koh Bong Y · CIK 0001615979 · 10% owner Venrock Healthcare Capital Partners II, L.P. · CIK 0001602264 · 10% owner Venrock Management IV, LLC · CIK 0001305238 · 10% owner Venrock Partners Management, LLC · CIK 0001305240 · 10% owner Venrock Partners, L.P. · CIK 0001305239 · 10% owner VHCP Co-Investment Holdings II, LLC · CIK 0001615983 · 10% owner VHCP Management II, LLC · CIK 0001602263 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · By funds Disclosed balance after: 6,824,425 F1 · date: This Form 4 is the first of two Form 4s being filed to report the beneficial ownership of the following Reporting Persons: Venrock Associates IV, LP, Venrock Partners, LP, Venrock Entrepreneurs Fund IV, LP, Venrock Management IV, LLC, Venrock Partners Management, LLC, VEF Management IV, LLC, Venrock Healthcare Capital Partners II, LP, VHCP Management II, LLC, VHCP Co Investment Holdings II, LLC, Venrock Healthcare Capital Partners III, LP, VHCP Management III, LLC, VHCP Co Investment Holdings III, LLC, Bong Koh and Nimish Shah. Two Form 4s are being filed because each form can report a maximum of 10 reporting persons. F2 · shares: Consists of: 316,797 shares sold by Venrock Healthcare Capital Partners II, LP, 128,431 shares sold by VHCP Co-Investment Holdings II, LLC, 235,791 shares sold by Venrock Healthcare Capital Partners III, LP and 23,576 shares sold by VHCP Co-Investment Holdings III, LLC. F3 · price: The price in Column 4 is a weighted average price. These shares were sold in multiple transactions a prices within a range of $1.00. The Reporting Persons undertake to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within this range. F4 · ownership.nature: Venrock Management IV, LLC ("VM4") is the general partner of Venrock Associates IV, LP. Venrock Partners Management, LLC ("VPM") is the general partner of Venrock Partners, LP. VEF Management IV, LLC ("VEFM") is the general partner of Venrock Entrepreneurs Fund IV, LP. VHCP Management II, LLC ("VHCPM2") is the general partner of Venrock Healthcare Capital Partners II, LP and the manager of VHCP Co-Investment Holdings II, LLC. VHCP Management III, LLC ("VHCPM3") is the general partner of Venrock Healthcare Capital Partners III, LP and the manager of VHCP Co-Investment Holdings III, LLC. Bong Koh and Nimish Shah are the managing members of VHCPM2 and VHCPM3. Each of VM4, VPM, VEFM, VHCPM2, VHCPM3, Bong Koh and Nimish Shah (together, the "Managers") may be deemed to beneficially own these shares. Each of the Managers expressly disclaims beneficial ownership over these shares except to the extent of their indirect pecuniary interests therein. Read SEC document |
| January 23, 2019 Filed Mar 14, 2019 17:51 UTC | Bellerophon Therapeutics, Inc. BLPH · Entity 108982 | PurchaseCommon Stock | 142,857 | $0.70 | $99,999.90 |
DisclosureSEC source: 0001209191-19-019526 · doc4.xml · nonDerivative · entry 1 VENROCK ASSOCIATES IV L P · CIK 0001277997 · 10% owner Venrock Partners, L.P. · CIK 0001305239 · 10% owner VENROCK ENTREPRENEURS FUND IV L P · CIK 0001277994 · 10% owner VEF Management IV, LLC · CIK 0001305243 · 10% owner Venrock Management IV, LLC · CIK 0001305238 · 10% owner Venrock Partners Management, LLC · CIK 0001305240 · 10% owner Venrock Healthcare Capital Partners II, L.P. · CIK 0001602264 · 10% owner VHCP Co-Investment Holdings II, LLC · CIK 0001615983 · 10% owner VHCP Management II, LLC · CIK 0001602263 · 10% owner Koh Bong Y · CIK 0001615979 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · By funds Disclosed balance after: 7,529,020 F1 · date: This Form 4 is the first of two Form 4s being filed to report the beneficial ownership of the following Reporting Persons: Venrock Associates IV, LP, Venrock Partners, LP, Venrock Entrepreneurs Fund IV, LP, Venrock Management IV, LLC, Venrock Partners Management, LLC, VEF Management IV, LLC, Venrock Healthcare Capital Partners II, LP, VHCP Management II, LLC, VHCP Co Investment Holdings II, LLC, Venrock Healthcare Capital Partners III, LP, VHCP Management III, LLC, VHCP Co Investment Holdings III, LLC, Bong Koh and Nimish Shah. Two Form 4s are being filed because each form can report a maximum of 10 reporting persons. F2 · ownership.nature: Consists of (i) 129,871 shares purchased by Venrock Healthcare Capital Partners III, LP and (ii) 12,986 shares purchased by VHCP Co-Investment Holdings III, LLC. F3 · ownership.nature: Venrock Management IV, LLC ("VM4") is the general partner of Venrock Associates IV, LP. Venrock Partners Management, LLC ("VPM") is the general partner of Venrock Partners, LP. VEF Management IV, LLC ("VEFM") is the general partner of Venrock Entrepreneurs Fund IV, LP. VHCP Management II, LLC ("VHCPM2") is the general partner of Venrock Healthcare Capital Partners II, LP and the manager of VHCP Co- Investment Holdings II, LLC. VHCP Management III, LLC ("VHCPM3") is the general partner of Venrock Healthcare Capital Partners III, LP and the manager of VHCP Co-Investment Holdings III, LLC. Bong Koh and Nimish Shah are the managing members of VHCPM2 and VHCPM3. Each of VM4, VPM, VEFM, VHCPM2, VHCPM3, Bong Koh and Nimish Shah (together, the "Managers") may be deemed to beneficially own these shares. Each of the Managers expressly disclaims beneficial ownership over these shares except to the extent of their indirect pecuniary interests therein. Read SEC document |
| September 17, 2018 Filed Sep 17, 2018 16:42 UTC | Bellerophon Therapeutics, Inc. BLPH · Entity 108982 | PurchaseCommon Stock | 60,000 | $1.18 | $70,944.00 |
DisclosureSEC source: 0001209191-18-051215 · doc4.xml · nonDerivative · entry 3 VENROCK ASSOCIATES IV L P · CIK 0001277997 · 10% owner Venrock Management IV, LLC · CIK 0001305238 · 10% owner Venrock Partners, L.P. · CIK 0001305239 · 10% owner Venrock Partners Management, LLC · CIK 0001305240 · 10% owner VENROCK ENTREPRENEURS FUND IV L P · CIK 0001277994 · 10% owner VEF Management IV, LLC · CIK 0001305243 · 10% owner Venrock Healthcare Capital Partners II, L.P. · CIK 0001602264 · 10% owner VHCP Co-Investment Holdings II, LLC · CIK 0001615983 · 10% owner VHCP Management II, LLC · CIK 0001602263 · 10% owner Koh Bong Y · CIK 0001615979 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · By funds Disclosed balance after: 7,386,163 F3 · ownership.nature: Venrock Management IV, LLC ("VM4") is the general partner of Venrock Associates IV, LP. Venrock Partners Management, LLC ("VPM") is the general partner of Venrock Partners, LP. VEF Management IV, LLC ("VEFM") is the general partner of Venrock Entrepreneurs Fund IV, LP. VHCP Management II, LLC ("VHCPM2") is the general partner of Venrock Healthcare Capital Partners II, LP and the manager of VHCP Co- Investment Holdings II, LLC. VHCP Management III, LLC ("VHCPM3") is the general partner of Venrock Healthcare Capital Partners III, LP and the manager of VHCP Co-Investment Holdings III, LLC. Bong Koh and Nimish Shah are the managing members of VHCPM2 and VHCPM3. Each of VM4, VPM, VEFM, VHCPM2, VHCPM3, Bong Koh and Nimish Shah (together, the "Managers") may be deemed to beneficially own these shares. Each of the Managers expressly disclaims beneficial ownership over these shares except to the extent of their indirect pecuniary interests therein. F4 · ownership.nature: Consists of (i) 54,546 shares purchased by Venrock Healthcare Capital Partners III, LP and (ii) 5,454 shares purchased by VHCP Co-Investment Holdings III, LLC. Read SEC document |
| September 14, 2018 Filed Sep 17, 2018 16:42 UTC | Bellerophon Therapeutics, Inc. BLPH · Entity 108982 | PurchaseCommon Stock | 75,000 | $1.23 | $92,250.00 |
DisclosureSEC source: 0001209191-18-051215 · doc4.xml · nonDerivative · entry 2 VENROCK ASSOCIATES IV L P · CIK 0001277997 · 10% owner Venrock Management IV, LLC · CIK 0001305238 · 10% owner Venrock Partners, L.P. · CIK 0001305239 · 10% owner Venrock Partners Management, LLC · CIK 0001305240 · 10% owner VENROCK ENTREPRENEURS FUND IV L P · CIK 0001277994 · 10% owner VEF Management IV, LLC · CIK 0001305243 · 10% owner Venrock Healthcare Capital Partners II, L.P. · CIK 0001602264 · 10% owner VHCP Co-Investment Holdings II, LLC · CIK 0001615983 · 10% owner VHCP Management II, LLC · CIK 0001602263 · 10% owner Koh Bong Y · CIK 0001615979 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · By funds Disclosed balance after: 7,326,163 F2 · ownership.nature: Consists of (i) 68,183 shares purchased by Venrock Healthcare Capital Partners III, LP and (ii) 6,817 shares purchased by VHCP Co-Investment Holdings III, LLC. F3 · ownership.nature: Venrock Management IV, LLC ("VM4") is the general partner of Venrock Associates IV, LP. Venrock Partners Management, LLC ("VPM") is the general partner of Venrock Partners, LP. VEF Management IV, LLC ("VEFM") is the general partner of Venrock Entrepreneurs Fund IV, LP. VHCP Management II, LLC ("VHCPM2") is the general partner of Venrock Healthcare Capital Partners II, LP and the manager of VHCP Co- Investment Holdings II, LLC. VHCP Management III, LLC ("VHCPM3") is the general partner of Venrock Healthcare Capital Partners III, LP and the manager of VHCP Co-Investment Holdings III, LLC. Bong Koh and Nimish Shah are the managing members of VHCPM2 and VHCPM3. Each of VM4, VPM, VEFM, VHCPM2, VHCPM3, Bong Koh and Nimish Shah (together, the "Managers") may be deemed to beneficially own these shares. Each of the Managers expressly disclaims beneficial ownership over these shares except to the extent of their indirect pecuniary interests therein. Read SEC document |
| September 13, 2018 Filed Sep 17, 2018 16:42 UTC | Bellerophon Therapeutics, Inc. BLPH · Entity 108982 | PurchaseCommon Stock | 75,000 | $1.19 | $89,160.00 |
DisclosureSEC source: 0001209191-18-051215 · doc4.xml · nonDerivative · entry 1 VENROCK ASSOCIATES IV L P · CIK 0001277997 · 10% owner Venrock Management IV, LLC · CIK 0001305238 · 10% owner Venrock Partners, L.P. · CIK 0001305239 · 10% owner Venrock Partners Management, LLC · CIK 0001305240 · 10% owner VENROCK ENTREPRENEURS FUND IV L P · CIK 0001277994 · 10% owner VEF Management IV, LLC · CIK 0001305243 · 10% owner Venrock Healthcare Capital Partners II, L.P. · CIK 0001602264 · 10% owner VHCP Co-Investment Holdings II, LLC · CIK 0001615983 · 10% owner VHCP Management II, LLC · CIK 0001602263 · 10% owner Koh Bong Y · CIK 0001615979 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · By funds Disclosed balance after: 7,251,163 F1 · date: This Form 4 is the first of two Form 4s being filed to report the beneficial ownership of the following Reporting Persons: Venrock Associates IV, LP, Venrock Partners, LP, Venrock Entrepreneurs Fund IV, LP, Venrock Management IV, LLC, Venrock Partners Management, LLC, VEF Management IV, LLC, Venrock Healthcare Capital Partners II, LP, VHCP Management II, LLC, VHCP Co Investment Holdings II, LLC, Venrock Healthcare Capital Partners III, LP, VHCP Management III, LLC, VHCP Co Investment Holdings III, LLC, Bong Koh and Nimish Shah. Two Form 4s are being filed because each form can report a maximum of 10 reporting persons. F2 · ownership.nature: Consists of (i) 68,183 shares purchased by Venrock Healthcare Capital Partners III, LP and (ii) 6,817 shares purchased by VHCP Co-Investment Holdings III, LLC. F3 · ownership.nature: Venrock Management IV, LLC ("VM4") is the general partner of Venrock Associates IV, LP. Venrock Partners Management, LLC ("VPM") is the general partner of Venrock Partners, LP. VEF Management IV, LLC ("VEFM") is the general partner of Venrock Entrepreneurs Fund IV, LP. VHCP Management II, LLC ("VHCPM2") is the general partner of Venrock Healthcare Capital Partners II, LP and the manager of VHCP Co- Investment Holdings II, LLC. VHCP Management III, LLC ("VHCPM3") is the general partner of Venrock Healthcare Capital Partners III, LP and the manager of VHCP Co-Investment Holdings III, LLC. Bong Koh and Nimish Shah are the managing members of VHCPM2 and VHCPM3. Each of VM4, VPM, VEFM, VHCPM2, VHCPM3, Bong Koh and Nimish Shah (together, the "Managers") may be deemed to beneficially own these shares. Each of the Managers expressly disclaims beneficial ownership over these shares except to the extent of their indirect pecuniary interests therein. Read SEC document |
| September 12, 2018 Filed Sep 12, 2018 21:00 UTC | Bellerophon Therapeutics, Inc. BLPH · Entity 108982 | PurchaseCommon Stock | 75,000 | $1.15 | $85,912.50 |
DisclosureSEC source: 0001209191-18-050736 · doc4.xml · nonDerivative · entry 3 VENROCK ASSOCIATES IV L P · CIK 0001277997 · 10% owner Venrock Management IV, LLC · CIK 0001305238 · 10% owner Venrock Partners, L.P. · CIK 0001305239 · 10% owner Venrock Partners Management, LLC · CIK 0001305240 · 10% owner VENROCK ENTREPRENEURS FUND IV L P · CIK 0001277994 · 10% owner VEF Management IV, LLC · CIK 0001305243 · 10% owner Venrock Healthcare Capital Partners II, L.P. · CIK 0001602264 · 10% owner VHCP Co-Investment Holdings II, LLC · CIK 0001615983 · 10% owner VHCP Management II, LLC · CIK 0001602263 · 10% owner Koh Bong Y · CIK 0001615979 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · By funds Disclosed balance after: 7,176,163 F4 · ownership.nature: Venrock Management IV, LLC ("VM4") is the general partner of Venrock Associates IV, LP. Venrock Partners Management, LLC ("VPM") is the general partner of Venrock Partners, LP. VEF Management IV, LLC ("VEFM") is the general partner of Venrock Entrepreneurs Fund IV, LP. VHCP Management II, LLC ("VHCPM2") is the general partner of Venrock Healthcare Capital Partners II, LP and the manager of VHCP Co-Investment Holdings II, LLC. VHCP Management III, LLC ("VHCPM3") is the general partner of Venrock Healthcare Capital Partners III, LP and the manager of VHCP Co-Investment Holdings III, LLC. Bong Koh and Nimish Shah are the managing members of VHCPM2 and VHCPM3. Each of VM4, VPM, VEFM, VHCPM2, VHCPM3, Bong Koh and Nimish Shah (together, the "Managers") may be deemed to beneficially own these shares. Each of the Managers expressly disclaims beneficial ownership over these shares except to the extent of their indirect pecuniary interests therein. F6 · ownership.nature: Consists of (i) 68,183 shares purchased by Venrock Healthcare Capital Partners III, LP and (ii) 6,817 shares purchased by VHCP Co-Investment Holdings III, LLC. Read SEC document |
| September 11, 2018 Filed Sep 12, 2018 21:00 UTC | Bellerophon Therapeutics, Inc. BLPH · Entity 108982 | PurchaseCommon Stock | 200,000 | $1.14 | $228,840.00 |
DisclosureSEC source: 0001209191-18-050736 · doc4.xml · nonDerivative · entry 2 VENROCK ASSOCIATES IV L P · CIK 0001277997 · 10% owner Venrock Management IV, LLC · CIK 0001305238 · 10% owner Venrock Partners, L.P. · CIK 0001305239 · 10% owner Venrock Partners Management, LLC · CIK 0001305240 · 10% owner VENROCK ENTREPRENEURS FUND IV L P · CIK 0001277994 · 10% owner VEF Management IV, LLC · CIK 0001305243 · 10% owner Venrock Healthcare Capital Partners II, L.P. · CIK 0001602264 · 10% owner VHCP Co-Investment Holdings II, LLC · CIK 0001615983 · 10% owner VHCP Management II, LLC · CIK 0001602263 · 10% owner Koh Bong Y · CIK 0001615979 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · By funds Disclosed balance after: 7,101,163 F5 · price: The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $1.10894 to $1.1990, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth herein. F3 · ownership.nature: Consists of (i) 181,820 shares purchased by Venrock Healthcare Capital Partners III, LP and (ii) 18,180 shares purchased by VHCP Co-Investment Holdings III, LLC. F4 · ownership.nature: Venrock Management IV, LLC ("VM4") is the general partner of Venrock Associates IV, LP. Venrock Partners Management, LLC ("VPM") is the general partner of Venrock Partners, LP. VEF Management IV, LLC ("VEFM") is the general partner of Venrock Entrepreneurs Fund IV, LP. VHCP Management II, LLC ("VHCPM2") is the general partner of Venrock Healthcare Capital Partners II, LP and the manager of VHCP Co-Investment Holdings II, LLC. VHCP Management III, LLC ("VHCPM3") is the general partner of Venrock Healthcare Capital Partners III, LP and the manager of VHCP Co-Investment Holdings III, LLC. Bong Koh and Nimish Shah are the managing members of VHCPM2 and VHCPM3. Each of VM4, VPM, VEFM, VHCPM2, VHCPM3, Bong Koh and Nimish Shah (together, the "Managers") may be deemed to beneficially own these shares. Each of the Managers expressly disclaims beneficial ownership over these shares except to the extent of their indirect pecuniary interests therein. Read SEC document |
| September 10, 2018 Filed Sep 12, 2018 21:00 UTC | Bellerophon Therapeutics, Inc. BLPH · Entity 108982 | PurchaseCommon Stock | 200,000 | $1.22 | $243,640.00 |
DisclosureSEC source: 0001209191-18-050736 · doc4.xml · nonDerivative · entry 1 VENROCK ASSOCIATES IV L P · CIK 0001277997 · 10% owner Venrock Management IV, LLC · CIK 0001305238 · 10% owner Venrock Partners, L.P. · CIK 0001305239 · 10% owner Venrock Partners Management, LLC · CIK 0001305240 · 10% owner VENROCK ENTREPRENEURS FUND IV L P · CIK 0001277994 · 10% owner VEF Management IV, LLC · CIK 0001305243 · 10% owner Venrock Healthcare Capital Partners II, L.P. · CIK 0001602264 · 10% owner VHCP Co-Investment Holdings II, LLC · CIK 0001615983 · 10% owner VHCP Management II, LLC · CIK 0001602263 · 10% owner Koh Bong Y · CIK 0001615979 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · By funds Disclosed balance after: 6,901,163 F1 · date: This Form 4 is the first of two Form 4s being filed to report the beneficial ownership of the following Reporting Persons: Venrock Associates IV, LP, Venrock Partners, LP, Venrock Entrepreneurs Fund IV, LP, Venrock Management IV, LLC, Venrock Partners Management, LLC, VEF Management IV, LLC, Venrock Healthcare Capital Partners II, LP, VHCP Management II, LLC, VHCP Co Investment Holdings II, LLC, Venrock Healthcare Capital Partners III, LP, VHCP Management III, LLC, VHCP Co Investment Holdings III, LLC, Bong Koh and Nimish Shah. Two Form 4s are being filed because each form can report a maximum of 10 reporting persons. F2 · price: The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $1.2099 to $1.2265, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth herein. F3 · ownership.nature: Consists of (i) 181,820 shares purchased by Venrock Healthcare Capital Partners III, LP and (ii) 18,180 shares purchased by VHCP Co-Investment Holdings III, LLC. F4 · ownership.nature: Venrock Management IV, LLC ("VM4") is the general partner of Venrock Associates IV, LP. Venrock Partners Management, LLC ("VPM") is the general partner of Venrock Partners, LP. VEF Management IV, LLC ("VEFM") is the general partner of Venrock Entrepreneurs Fund IV, LP. VHCP Management II, LLC ("VHCPM2") is the general partner of Venrock Healthcare Capital Partners II, LP and the manager of VHCP Co-Investment Holdings II, LLC. VHCP Management III, LLC ("VHCPM3") is the general partner of Venrock Healthcare Capital Partners III, LP and the manager of VHCP Co-Investment Holdings III, LLC. Bong Koh and Nimish Shah are the managing members of VHCPM2 and VHCPM3. Each of VM4, VPM, VEFM, VHCPM2, VHCPM3, Bong Koh and Nimish Shah (together, the "Managers") may be deemed to beneficially own these shares. Each of the Managers expressly disclaims beneficial ownership over these shares except to the extent of their indirect pecuniary interests therein. Read SEC document |
| September 07, 2018 Filed Sep 7, 2018 17:45 UTC | Bellerophon Therapeutics, Inc. BLPH · Entity 108982 | PurchaseCommon Stock | 60,000 | $0.90 | $53,742.00 |
DisclosureSEC source: 0001209191-18-050122 · doc4.xml · nonDerivative · entry 3 VENROCK ASSOCIATES IV L P · CIK 0001277997 · 10% owner Venrock Management IV, LLC · CIK 0001305238 · 10% owner Venrock Partners, L.P. · CIK 0001305239 · 10% owner Venrock Partners Management, LLC · CIK 0001305240 · 10% owner VENROCK ENTREPRENEURS FUND IV L P · CIK 0001277994 · 10% owner VEF Management IV, LLC · CIK 0001305243 · 10% owner Venrock Healthcare Capital Partners II, L.P. · CIK 0001602264 · 10% owner VHCP Co-Investment Holdings II, LLC · CIK 0001615983 · 10% owner VHCP Management II, LLC · CIK 0001602263 · 10% owner Koh Bong Y · CIK 0001615979 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · By funds Disclosed balance after: 6,701,163 F3 · ownership.nature: Consists of (i) 54,546 shares purchased by Venrock Healthcare Capital Partners III, LP and (ii) 5,454 shares purchased by VHCP Co-Investment Holdings III, LLC. Read SEC document |
| September 06, 2018 Filed Sep 7, 2018 17:45 UTC | Bellerophon Therapeutics, Inc. BLPH · Entity 108982 | PurchaseCommon Stock | 50,000 | $0.84 | $42,095.00 |
DisclosureSEC source: 0001209191-18-050122 · doc4.xml · nonDerivative · entry 2 VENROCK ASSOCIATES IV L P · CIK 0001277997 · 10% owner Venrock Management IV, LLC · CIK 0001305238 · 10% owner Venrock Partners, L.P. · CIK 0001305239 · 10% owner Venrock Partners Management, LLC · CIK 0001305240 · 10% owner VENROCK ENTREPRENEURS FUND IV L P · CIK 0001277994 · 10% owner VEF Management IV, LLC · CIK 0001305243 · 10% owner Venrock Healthcare Capital Partners II, L.P. · CIK 0001602264 · 10% owner VHCP Co-Investment Holdings II, LLC · CIK 0001615983 · 10% owner VHCP Management II, LLC · CIK 0001602263 · 10% owner Koh Bong Y · CIK 0001615979 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · By funds Disclosed balance after: 6,641,163 F2 · ownership.nature: Consists of (i) 45,455 shares purchased by Venrock Healthcare Capital Partners III, LP and (ii) 4,545 shares purchased by VHCP Co-Investment Holdings III, LLC. Read SEC document |
| September 05, 2018 Filed Sep 7, 2018 17:45 UTC | Bellerophon Therapeutics, Inc. BLPH · Entity 108982 | PurchaseCommon Stock | 50,000 | $0.85 | $42,325.00 |
DisclosureSEC source: 0001209191-18-050122 · doc4.xml · nonDerivative · entry 1 VENROCK ASSOCIATES IV L P · CIK 0001277997 · 10% owner Venrock Management IV, LLC · CIK 0001305238 · 10% owner Venrock Partners, L.P. · CIK 0001305239 · 10% owner Venrock Partners Management, LLC · CIK 0001305240 · 10% owner VENROCK ENTREPRENEURS FUND IV L P · CIK 0001277994 · 10% owner VEF Management IV, LLC · CIK 0001305243 · 10% owner Venrock Healthcare Capital Partners II, L.P. · CIK 0001602264 · 10% owner VHCP Co-Investment Holdings II, LLC · CIK 0001615983 · 10% owner VHCP Management II, LLC · CIK 0001602263 · 10% owner Koh Bong Y · CIK 0001615979 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · By funds Disclosed balance after: 6,591,163 F1 · date: This Form 4 is the first of two Form 4s being filed to report the beneficial ownership of the following Reporting Persons: Venrock Associates IV, LP, Venrock Partners, LP, Venrock Entrepreneurs Fund IV, LP, Venrock Management IV, LLC, Venrock Partners Management, LLC, VEF Management IV, LLC, Venrock Healthcare Capital Partners II, LP, VHCP Management II, LLC, VHCP Co Investment Holdings II, LLC, Venrock Healthcare Capital Partners III, LP, VHCP Management III, LLC, VHCP Co Investment Holdings III, LLC, Bong Koh and Nimish Shah. Two Form 4s are being filed because each form can report a maximum of 10 reporting persons. F2 · ownership.nature: Consists of (i) 45,455 shares purchased by Venrock Healthcare Capital Partners III, LP and (ii) 4,545 shares purchased by VHCP Co-Investment Holdings III, LLC. Read SEC document |
| August 16, 2018 Filed Aug 16, 2018 19:31 UTC | Bellerophon Therapeutics, Inc. BLPH · Entity 108982 | PurchaseCommon Stock | 66,393 | $0.65 | $43,108.97 |
DisclosureSEC source: 0001209191-18-047212 · doc4.xml · nonDerivative · entry 3 VENROCK ASSOCIATES IV L P · CIK 0001277997 · 10% owner Venrock Partners, L.P. · CIK 0001305239 · 10% owner Venrock Partners Management, LLC · CIK 0001305240 · 10% owner Venrock Management IV, LLC · CIK 0001305238 · 10% owner VENROCK ENTREPRENEURS FUND IV L P · CIK 0001277994 · 10% owner VEF Management IV, LLC · CIK 0001305243 · 10% owner Venrock Healthcare Capital Partners II, L.P. · CIK 0001602264 · 10% owner VHCP Management II, LLC · CIK 0001602263 · 10% owner VHCP Co-Investment Holdings II, LLC · CIK 0001615983 · 10% owner Koh Bong Y · CIK 0001615979 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · By funds Disclosed balance after: 6,541,163 F4 · ownership.direct: Consists of (i) 60,358 shares purchased by Venrock Healthcare Capital Partners III, LP and (ii) 6,035 shares purchased by VHCP Co-Investment Holdings II, LLC. Read SEC document |
| August 15, 2018 Filed Aug 16, 2018 19:31 UTC | Bellerophon Therapeutics, Inc. BLPH · Entity 108982 | PurchaseCommon Stock | 272,000 | $0.65 | $175,902.40 |
DisclosureSEC source: 0001209191-18-047212 · doc4.xml · nonDerivative · entry 2 VENROCK ASSOCIATES IV L P · CIK 0001277997 · 10% owner Venrock Partners, L.P. · CIK 0001305239 · 10% owner Venrock Partners Management, LLC · CIK 0001305240 · 10% owner Venrock Management IV, LLC · CIK 0001305238 · 10% owner VENROCK ENTREPRENEURS FUND IV L P · CIK 0001277994 · 10% owner VEF Management IV, LLC · CIK 0001305243 · 10% owner Venrock Healthcare Capital Partners II, L.P. · CIK 0001602264 · 10% owner VHCP Management II, LLC · CIK 0001602263 · 10% owner VHCP Co-Investment Holdings II, LLC · CIK 0001615983 · 10% owner Koh Bong Y · CIK 0001615979 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · By funds Disclosed balance after: 6,474,770 F3 · ownership.direct: Consists of (i) 247,275 shares purchased by Venrock Healthcare Capital Partners III, LP and (ii) 24,725 shares purchased by VHCP Co-Investment Holdings III, LLC. Read SEC document |
| August 14, 2018 Filed Aug 16, 2018 19:31 UTC | Bellerophon Therapeutics, Inc. BLPH · Entity 108982 | PurchaseCommon Stock | 190,977 | $0.65 | $123,867.68 |
DisclosureSEC source: 0001209191-18-047212 · doc4.xml · nonDerivative · entry 1 VENROCK ASSOCIATES IV L P · CIK 0001277997 · 10% owner Venrock Partners, L.P. · CIK 0001305239 · 10% owner Venrock Partners Management, LLC · CIK 0001305240 · 10% owner Venrock Management IV, LLC · CIK 0001305238 · 10% owner VENROCK ENTREPRENEURS FUND IV L P · CIK 0001277994 · 10% owner VEF Management IV, LLC · CIK 0001305243 · 10% owner Venrock Healthcare Capital Partners II, L.P. · CIK 0001602264 · 10% owner VHCP Management II, LLC · CIK 0001602263 · 10% owner VHCP Co-Investment Holdings II, LLC · CIK 0001615983 · 10% owner Koh Bong Y · CIK 0001615979 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · By funds Disclosed balance after: 6,202,770 F1 · date: This Form 4 is the first of two Form 4s being filed to report the beneficial ownership of the following Reporting Persons: Venrock Associates IV, LP, Venrock Partners, LP, Venrock Entrepreneurs Fund IV, LP, Venrock Management IV, LLC, Venrock Partners Management, LLC, VEF Management IV, LLC, Venrock Healthcare Capital Partners II, LP, VHCP Management II, LLC, VHCP Co-Investment Holdings II, LLC, Bong Koh and Nimish Shah. Two Form 4s are being filed because each form can report a maximum of 10 reporting persons. F2 · ownership.direct: Consists of (i) 173,617 shares purchased by Venrock Healthcare Capital Partners III, LP and (ii) 17,360 shares purchased by VHCP Co-Investment Holdings III, LLC. Read SEC document |
| November 02, 2016 Filed Nov 4, 2016 19:57 UTC | ON Semiconductor Connectivity Solutions, Inc. QTNA · Entity 156540 | ConversionSeries G Preferred Stock · Derivative | 60,551 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-16-148511 · doc4.xml · derivative · entry 14 VENROCK ASSOCIATES IV L P · CIK 0001277997 · 10% owner Venrock Partners, L.P. · CIK 0001305239 · 10% owner VENROCK ENTREPRENEURS FUND IV L P · CIK 0001277994 · 10% owner Venrock Management IV, LLC · CIK 0001305238 · 10% owner Venrock Partners Management, LLC · CIK 0001305240 · 10% owner VEF Management IV, LLC · CIK 0001305243 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · See footnote Disclosed balance after: 0 Underlying: Common Stock · 60,551 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F7 · derivative.exercise_price: The Series G Preferred Stock automatically converted into Common Stock on a 1:1 basis immediately prior to the closing of the Issuer's initial public offering and had no expiration date. F22 · shares: Consisted of an aggregate of 49,289 shares of Series G Preferred Stock held by Venrock IV, 10,051 shares of Series G Preferred Stock held by Venrock Partners, and 1,211 shares of Series G Preferred Stock held by Venrock Entrepreneurs. VM4, VPM and VEFM4 disclaim beneficial ownership over all shares held by Venrock IV, Venrock Partners and Venrock Entrepreneurs, except to the extent of their indirect pecuniary interests therein. F7 · derivative.exercise_date: The Series G Preferred Stock automatically converted into Common Stock on a 1:1 basis immediately prior to the closing of the Issuer's initial public offering and had no expiration date. F7 · derivative.expiration_date: The Series G Preferred Stock automatically converted into Common Stock on a 1:1 basis immediately prior to the closing of the Issuer's initial public offering and had no expiration date. F16 · ownership.nature: The sole general partner of Venrock IV is Venrock Management IV, LLC ("VM4"). The sole general partner of Venrock Partners is Venrock Partners Management, LLC ("VPM"). The sole general partner of Venrock Entrepreneurs is VEF Management IV, LLC ("VEFM4"). F22 · ownership.nature: Consisted of an aggregate of 49,289 shares of Series G Preferred Stock held by Venrock IV, 10,051 shares of Series G Preferred Stock held by Venrock Partners, and 1,211 shares of Series G Preferred Stock held by Venrock Entrepreneurs. VM4, VPM and VEFM4 disclaim beneficial ownership over all shares held by Venrock IV, Venrock Partners and Venrock Entrepreneurs, except to the extent of their indirect pecuniary interests therein. Read SEC document |
| November 02, 2016 Filed Nov 4, 2016 19:57 UTC | ON Semiconductor Connectivity Solutions, Inc. QTNA · Entity 156540 | ConversionSeries F-1 Preferred Stock · Derivative | 383,634 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-16-148511 · doc4.xml · derivative · entry 13 VENROCK ASSOCIATES IV L P · CIK 0001277997 · 10% owner Venrock Partners, L.P. · CIK 0001305239 · 10% owner VENROCK ENTREPRENEURS FUND IV L P · CIK 0001277994 · 10% owner Venrock Management IV, LLC · CIK 0001305238 · 10% owner Venrock Partners Management, LLC · CIK 0001305240 · 10% owner VEF Management IV, LLC · CIK 0001305243 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · See footnote Disclosed balance after: 0 Underlying: Common Stock · 383,634 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F6 · derivative.exercise_price: The Series F-1 Preferred Stock automatically converted into Common Stock on a 1:1 basis immediately prior to the closing of the Issuer's initial public offering and had no expiration date. F21 · shares: Consisted of an aggregate of 312,279 shares of Series F-1 Preferred Stock held by Venrock IV, 63,683 shares of Series F-1 Preferred Stock held by Venrock Partners, and 7,672 shares of Series F-1 Preferred Stock held by Venrock Entrepreneurs. VM4, VPM and VEFM4 disclaim beneficial ownership over all shares held by Venrock IV, Venrock Partners and Venrock Entrepreneurs, except to the extent of their indirect pecuniary interests therein. F6 · derivative.exercise_date: The Series F-1 Preferred Stock automatically converted into Common Stock on a 1:1 basis immediately prior to the closing of the Issuer's initial public offering and had no expiration date. F6 · derivative.expiration_date: The Series F-1 Preferred Stock automatically converted into Common Stock on a 1:1 basis immediately prior to the closing of the Issuer's initial public offering and had no expiration date. F16 · ownership.nature: The sole general partner of Venrock IV is Venrock Management IV, LLC ("VM4"). The sole general partner of Venrock Partners is Venrock Partners Management, LLC ("VPM"). The sole general partner of Venrock Entrepreneurs is VEF Management IV, LLC ("VEFM4"). F21 · ownership.nature: Consisted of an aggregate of 312,279 shares of Series F-1 Preferred Stock held by Venrock IV, 63,683 shares of Series F-1 Preferred Stock held by Venrock Partners, and 7,672 shares of Series F-1 Preferred Stock held by Venrock Entrepreneurs. VM4, VPM and VEFM4 disclaim beneficial ownership over all shares held by Venrock IV, Venrock Partners and Venrock Entrepreneurs, except to the extent of their indirect pecuniary interests therein. Read SEC document |
| November 02, 2016 Filed Nov 4, 2016 19:57 UTC | ON Semiconductor Connectivity Solutions, Inc. QTNA · Entity 156540 | ConversionSeries E Preferred Stock · Derivative | 469,779 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-16-148511 · doc4.xml · derivative · entry 12 VENROCK ASSOCIATES IV L P · CIK 0001277997 · 10% owner Venrock Partners, L.P. · CIK 0001305239 · 10% owner VENROCK ENTREPRENEURS FUND IV L P · CIK 0001277994 · 10% owner Venrock Management IV, LLC · CIK 0001305238 · 10% owner Venrock Partners Management, LLC · CIK 0001305240 · 10% owner VEF Management IV, LLC · CIK 0001305243 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · See footnote Disclosed balance after: 0 Underlying: Common Stock · 469,779 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F5 · derivative.exercise_price: The Series E Preferred Stock automatically converted into Common Stock on a 1:1 basis immediately prior to the closing of the Issuer's initial public offering and had no expiration date. F20 · shares: Consisted of an aggregate of 382,401 shares of Series E Preferred Stock held by Venrock IV, 77,983 shares of Series E Preferred Stock held by Venrock Partners, and 9,395 shares of Series E Preferred Stock held by Venrock Entrepreneurs. VM4, VPM and VEFM4 disclaim beneficial ownership over all shares held by Venrock IV, Venrock Partners and Venrock Entrepreneurs, except to the extent of their indirect pecuniary interests therein. F5 · derivative.exercise_date: The Series E Preferred Stock automatically converted into Common Stock on a 1:1 basis immediately prior to the closing of the Issuer's initial public offering and had no expiration date. F5 · derivative.expiration_date: The Series E Preferred Stock automatically converted into Common Stock on a 1:1 basis immediately prior to the closing of the Issuer's initial public offering and had no expiration date. F16 · ownership.nature: The sole general partner of Venrock IV is Venrock Management IV, LLC ("VM4"). The sole general partner of Venrock Partners is Venrock Partners Management, LLC ("VPM"). The sole general partner of Venrock Entrepreneurs is VEF Management IV, LLC ("VEFM4"). F20 · ownership.nature: Consisted of an aggregate of 382,401 shares of Series E Preferred Stock held by Venrock IV, 77,983 shares of Series E Preferred Stock held by Venrock Partners, and 9,395 shares of Series E Preferred Stock held by Venrock Entrepreneurs. VM4, VPM and VEFM4 disclaim beneficial ownership over all shares held by Venrock IV, Venrock Partners and Venrock Entrepreneurs, except to the extent of their indirect pecuniary interests therein. Read SEC document |
| November 02, 2016 Filed Nov 4, 2016 19:57 UTC | ON Semiconductor Connectivity Solutions, Inc. QTNA · Entity 156540 | ConversionSeries D Preferred Stock · Derivative | 805,625 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-16-148511 · doc4.xml · derivative · entry 11 VENROCK ASSOCIATES IV L P · CIK 0001277997 · 10% owner Venrock Partners, L.P. · CIK 0001305239 · 10% owner VENROCK ENTREPRENEURS FUND IV L P · CIK 0001277994 · 10% owner Venrock Management IV, LLC · CIK 0001305238 · 10% owner Venrock Partners Management, LLC · CIK 0001305240 · 10% owner VEF Management IV, LLC · CIK 0001305243 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · See footnote Disclosed balance after: 0 Underlying: Common Stock · 805,625 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_price: The Series D Preferred Stock automatically converted into Common Stock on a 1:1 basis immediately prior to the closing of the Issuer's initial public offering and had no expiration date. F19 · shares: Consisted of an aggregate of 655,780 shares of Series D Preferred Stock held by Venrock IV, 133,734 shares of Series D Preferred Stock held by Venrock Partners, and 16,111 shares of Series D Preferred Stock held by Venrock Entrepreneurs. VM4, VPM and VEFM4 disclaim beneficial ownership over all shares held by Venrock IV, Venrock Partners and Venrock Entrepreneurs, except to the extent of their indirect pecuniary interests therein. F4 · derivative.exercise_date: The Series D Preferred Stock automatically converted into Common Stock on a 1:1 basis immediately prior to the closing of the Issuer's initial public offering and had no expiration date. F4 · derivative.expiration_date: The Series D Preferred Stock automatically converted into Common Stock on a 1:1 basis immediately prior to the closing of the Issuer's initial public offering and had no expiration date. F16 · ownership.nature: The sole general partner of Venrock IV is Venrock Management IV, LLC ("VM4"). The sole general partner of Venrock Partners is Venrock Partners Management, LLC ("VPM"). The sole general partner of Venrock Entrepreneurs is VEF Management IV, LLC ("VEFM4"). F19 · ownership.nature: Consisted of an aggregate of 655,780 shares of Series D Preferred Stock held by Venrock IV, 133,734 shares of Series D Preferred Stock held by Venrock Partners, and 16,111 shares of Series D Preferred Stock held by Venrock Entrepreneurs. VM4, VPM and VEFM4 disclaim beneficial ownership over all shares held by Venrock IV, Venrock Partners and Venrock Entrepreneurs, except to the extent of their indirect pecuniary interests therein. Read SEC document |
| November 02, 2016 Filed Nov 4, 2016 19:57 UTC | ON Semiconductor Connectivity Solutions, Inc. QTNA · Entity 156540 | ConversionSeries C Preferred Stock · Derivative | 94,321 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-16-148511 · doc4.xml · derivative · entry 10 VENROCK ASSOCIATES IV L P · CIK 0001277997 · 10% owner Venrock Partners, L.P. · CIK 0001305239 · 10% owner VENROCK ENTREPRENEURS FUND IV L P · CIK 0001277994 · 10% owner Venrock Management IV, LLC · CIK 0001305238 · 10% owner Venrock Partners Management, LLC · CIK 0001305240 · 10% owner VEF Management IV, LLC · CIK 0001305243 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · See footnote Disclosed balance after: 0 Underlying: Common Stock · 186,644 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_price: The Series C Preferred Stock automatically converted into Common Stock on a 1.97882655585238:1 basis immediately prior to the closing of the Issuer's initial public offering and had no expiration date. F18 · shares: Consisted of an aggregate of 76,778 shares of Series C Preferred Stock held by Venrock IV, 15,657 shares of Series C Preferred Stock held by Venrock Partners, and 1,886 shares of Series C Preferred Stock held by Venrock Entrepreneurs. VM4, VPM and VEFM4 disclaim beneficial ownership over all shares held by Venrock IV, Venrock Partners and Venrock Entrepreneurs, except to the extent of their indirect pecuniary interests therein. F3 · derivative.exercise_date: The Series C Preferred Stock automatically converted into Common Stock on a 1.97882655585238:1 basis immediately prior to the closing of the Issuer's initial public offering and had no expiration date. F3 · derivative.expiration_date: The Series C Preferred Stock automatically converted into Common Stock on a 1.97882655585238:1 basis immediately prior to the closing of the Issuer's initial public offering and had no expiration date. F16 · ownership.nature: The sole general partner of Venrock IV is Venrock Management IV, LLC ("VM4"). The sole general partner of Venrock Partners is Venrock Partners Management, LLC ("VPM"). The sole general partner of Venrock Entrepreneurs is VEF Management IV, LLC ("VEFM4"). F18 · ownership.nature: Consisted of an aggregate of 76,778 shares of Series C Preferred Stock held by Venrock IV, 15,657 shares of Series C Preferred Stock held by Venrock Partners, and 1,886 shares of Series C Preferred Stock held by Venrock Entrepreneurs. VM4, VPM and VEFM4 disclaim beneficial ownership over all shares held by Venrock IV, Venrock Partners and Venrock Entrepreneurs, except to the extent of their indirect pecuniary interests therein. Read SEC document |
| November 02, 2016 Filed Nov 4, 2016 19:57 UTC | ON Semiconductor Connectivity Solutions, Inc. QTNA · Entity 156540 | ConversionSeries B Preferred Stock · Derivative | 71,744 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-16-148511 · doc4.xml · derivative · entry 9 VENROCK ASSOCIATES IV L P · CIK 0001277997 · 10% owner Venrock Partners, L.P. · CIK 0001305239 · 10% owner VENROCK ENTREPRENEURS FUND IV L P · CIK 0001277994 · 10% owner Venrock Management IV, LLC · CIK 0001305238 · 10% owner Venrock Partners Management, LLC · CIK 0001305240 · 10% owner VEF Management IV, LLC · CIK 0001305243 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · See footnote Disclosed balance after: 0 Underlying: Common Stock · 138,696 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: The Series B Preferred Stock automatically converted into Common Stock on a 1.9332015399022:1 basis immediately prior to the closing of the Issuer's initial public offering and had no expiration date. F17 · shares: Consisted of an aggregate of 58,401 shares of Series B Preferred Stock held by Venrock IV, 11,909 shares of Series B Preferred Stock held by Venrock Partners, and 1,434 shares of Series B Preferred Stock held by Venrock Entrepreneurs. VM4, VPM and VEFM4 disclaim beneficial ownership over all shares held by Venrock IV, Venrock Partners and Venrock Entrepreneurs, except to the extent of their indirect pecuniary interests therein. F2 · derivative.exercise_date: The Series B Preferred Stock automatically converted into Common Stock on a 1.9332015399022:1 basis immediately prior to the closing of the Issuer's initial public offering and had no expiration date. F2 · derivative.expiration_date: The Series B Preferred Stock automatically converted into Common Stock on a 1.9332015399022:1 basis immediately prior to the closing of the Issuer's initial public offering and had no expiration date. F16 · ownership.nature: The sole general partner of Venrock IV is Venrock Management IV, LLC ("VM4"). The sole general partner of Venrock Partners is Venrock Partners Management, LLC ("VPM"). The sole general partner of Venrock Entrepreneurs is VEF Management IV, LLC ("VEFM4"). F17 · ownership.nature: Consisted of an aggregate of 58,401 shares of Series B Preferred Stock held by Venrock IV, 11,909 shares of Series B Preferred Stock held by Venrock Partners, and 1,434 shares of Series B Preferred Stock held by Venrock Entrepreneurs. VM4, VPM and VEFM4 disclaim beneficial ownership over all shares held by Venrock IV, Venrock Partners and Venrock Entrepreneurs, except to the extent of their indirect pecuniary interests therein. Read SEC document |
| November 02, 2016 Filed Nov 4, 2016 19:57 UTC | ON Semiconductor Connectivity Solutions, Inc. QTNA · Entity 156540 | ConversionSeries A Preferred Stock · Derivative | 322,411 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-16-148511 · doc4.xml · derivative · entry 8 VENROCK ASSOCIATES IV L P · CIK 0001277997 · 10% owner Venrock Partners, L.P. · CIK 0001305239 · 10% owner VENROCK ENTREPRENEURS FUND IV L P · CIK 0001277994 · 10% owner Venrock Management IV, LLC · CIK 0001305238 · 10% owner Venrock Partners Management, LLC · CIK 0001305240 · 10% owner VEF Management IV, LLC · CIK 0001305243 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · See footnote Disclosed balance after: 0 Underlying: Common Stock · 608,340 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: The Series A Preferred Stock automatically converted into Common Stock on a 1.8868501529052:1 basis immediately prior to the closing of the Issuer's initial public offering and had no expiration date. F15 · shares: Consisted of an aggregate of 262,443 shares of Series A Preferred Stock held by Venrock IV, 53,520 shares of Series A Preferred Stock held by Venrock Partners, and 6,448 shares of Series A Preferred Stock held by Venrock Entrepreneurs. VM4, VPM and VEFM4 disclaim beneficial ownership over all shares held by Venrock IV, Venrock Partners and Venrock Entrepreneurs, except to the extent of their indirect pecuniary interests therein. F1 · derivative.exercise_date: The Series A Preferred Stock automatically converted into Common Stock on a 1.8868501529052:1 basis immediately prior to the closing of the Issuer's initial public offering and had no expiration date. F1 · derivative.expiration_date: The Series A Preferred Stock automatically converted into Common Stock on a 1.8868501529052:1 basis immediately prior to the closing of the Issuer's initial public offering and had no expiration date. F15 · ownership.nature: Consisted of an aggregate of 262,443 shares of Series A Preferred Stock held by Venrock IV, 53,520 shares of Series A Preferred Stock held by Venrock Partners, and 6,448 shares of Series A Preferred Stock held by Venrock Entrepreneurs. VM4, VPM and VEFM4 disclaim beneficial ownership over all shares held by Venrock IV, Venrock Partners and Venrock Entrepreneurs, except to the extent of their indirect pecuniary interests therein. F16 · ownership.nature: The sole general partner of Venrock IV is Venrock Management IV, LLC ("VM4"). The sole general partner of Venrock Partners is Venrock Partners Management, LLC ("VPM"). The sole general partner of Venrock Entrepreneurs is VEF Management IV, LLC ("VEFM4"). Read SEC document |
| November 02, 2016 Filed Nov 4, 2016 19:57 UTC | ON Semiconductor Connectivity Solutions, Inc. QTNA · Entity 156540 | ConversionCommon Stock | 60,551 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001209191-16-148511 · doc4.xml · nonDerivative · entry 7 VENROCK ASSOCIATES IV L P · CIK 0001277997 · 10% owner Venrock Partners, L.P. · CIK 0001305239 · 10% owner VENROCK ENTREPRENEURS FUND IV L P · CIK 0001277994 · 10% owner Venrock Management IV, LLC · CIK 0001305238 · 10% owner Venrock Partners Management, LLC · CIK 0001305240 · 10% owner VEF Management IV, LLC · CIK 0001305243 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · See footnote Disclosed balance after: 2,653,269 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: The Series A Preferred Stock automatically converted into Common Stock on a 1.8868501529052:1 basis immediately prior to the closing of the Issuer's initial public offering and had no expiration date. F2 · price: The Series B Preferred Stock automatically converted into Common Stock on a 1.9332015399022:1 basis immediately prior to the closing of the Issuer's initial public offering and had no expiration date. F3 · price: The Series C Preferred Stock automatically converted into Common Stock on a 1.97882655585238:1 basis immediately prior to the closing of the Issuer's initial public offering and had no expiration date. F4 · price: The Series D Preferred Stock automatically converted into Common Stock on a 1:1 basis immediately prior to the closing of the Issuer's initial public offering and had no expiration date. F5 · price: The Series E Preferred Stock automatically converted into Common Stock on a 1:1 basis immediately prior to the closing of the Issuer's initial public offering and had no expiration date. F6 · price: The Series F-1 Preferred Stock automatically converted into Common Stock on a 1:1 basis immediately prior to the closing of the Issuer's initial public offering and had no expiration date. F7 · price: The Series G Preferred Stock automatically converted into Common Stock on a 1:1 basis immediately prior to the closing of the Issuer's initial public offering and had no expiration date. F14 · ownership.nature: Consists of an aggregate of 2,159,770 shares of Common Stock held by Venrock IV, 440,440 shares of Common Stock held by Venrock Partners, and 53,059 shares of Common Stock held by Venrock Entrepreneurs. VM4, VPM and VEFM4 disclaim beneficial ownership over all shares held by Venrock IV, Venrock Partners and Venrock Entrepreneurs, except to the extent of their indirect pecuniary interests therein. Read SEC document |
| November 02, 2016 Filed Nov 4, 2016 19:57 UTC | ON Semiconductor Connectivity Solutions, Inc. QTNA · Entity 156540 | ConversionCommon Stock | 383,634 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001209191-16-148511 · doc4.xml · nonDerivative · entry 6 VENROCK ASSOCIATES IV L P · CIK 0001277997 · 10% owner Venrock Partners, L.P. · CIK 0001305239 · 10% owner VENROCK ENTREPRENEURS FUND IV L P · CIK 0001277994 · 10% owner Venrock Management IV, LLC · CIK 0001305238 · 10% owner Venrock Partners Management, LLC · CIK 0001305240 · 10% owner VEF Management IV, LLC · CIK 0001305243 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · See footnote Disclosed balance after: 2,592,718 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: The Series A Preferred Stock automatically converted into Common Stock on a 1.8868501529052:1 basis immediately prior to the closing of the Issuer's initial public offering and had no expiration date. F2 · price: The Series B Preferred Stock automatically converted into Common Stock on a 1.9332015399022:1 basis immediately prior to the closing of the Issuer's initial public offering and had no expiration date. F3 · price: The Series C Preferred Stock automatically converted into Common Stock on a 1.97882655585238:1 basis immediately prior to the closing of the Issuer's initial public offering and had no expiration date. F4 · price: The Series D Preferred Stock automatically converted into Common Stock on a 1:1 basis immediately prior to the closing of the Issuer's initial public offering and had no expiration date. F5 · price: The Series E Preferred Stock automatically converted into Common Stock on a 1:1 basis immediately prior to the closing of the Issuer's initial public offering and had no expiration date. F6 · price: The Series F-1 Preferred Stock automatically converted into Common Stock on a 1:1 basis immediately prior to the closing of the Issuer's initial public offering and had no expiration date. F7 · price: The Series G Preferred Stock automatically converted into Common Stock on a 1:1 basis immediately prior to the closing of the Issuer's initial public offering and had no expiration date. F13 · ownership.nature: Consists of an aggregate of 2,110,481 shares of Common Stock held by Venrock IV, 430,389 shares of Common Stock held by Venrock Partners, and 51,848 shares of Common Stock held by Venrock Entrepreneurs. VM4, VPM and VEFM4 disclaim beneficial ownership over all shares held by Venrock IV, Venrock Partners and Venrock Entrepreneurs, except to the extent of their indirect pecuniary interests therein. Read SEC document |
| November 02, 2016 Filed Nov 4, 2016 19:57 UTC | ON Semiconductor Connectivity Solutions, Inc. QTNA · Entity 156540 | ConversionCommon Stock | 469,779 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001209191-16-148511 · doc4.xml · nonDerivative · entry 5 VENROCK ASSOCIATES IV L P · CIK 0001277997 · 10% owner Venrock Partners, L.P. · CIK 0001305239 · 10% owner VENROCK ENTREPRENEURS FUND IV L P · CIK 0001277994 · 10% owner Venrock Management IV, LLC · CIK 0001305238 · 10% owner Venrock Partners Management, LLC · CIK 0001305240 · 10% owner VEF Management IV, LLC · CIK 0001305243 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · See footnote Disclosed balance after: 2,209,084 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: The Series A Preferred Stock automatically converted into Common Stock on a 1.8868501529052:1 basis immediately prior to the closing of the Issuer's initial public offering and had no expiration date. F2 · price: The Series B Preferred Stock automatically converted into Common Stock on a 1.9332015399022:1 basis immediately prior to the closing of the Issuer's initial public offering and had no expiration date. F3 · price: The Series C Preferred Stock automatically converted into Common Stock on a 1.97882655585238:1 basis immediately prior to the closing of the Issuer's initial public offering and had no expiration date. F4 · price: The Series D Preferred Stock automatically converted into Common Stock on a 1:1 basis immediately prior to the closing of the Issuer's initial public offering and had no expiration date. F5 · price: The Series E Preferred Stock automatically converted into Common Stock on a 1:1 basis immediately prior to the closing of the Issuer's initial public offering and had no expiration date. F6 · price: The Series F-1 Preferred Stock automatically converted into Common Stock on a 1:1 basis immediately prior to the closing of the Issuer's initial public offering and had no expiration date. F7 · price: The Series G Preferred Stock automatically converted into Common Stock on a 1:1 basis immediately prior to the closing of the Issuer's initial public offering and had no expiration date. F12 · ownership.nature: Consists of an aggregate of 1,798,202 shares of Common Stock held by Venrock IV, 366,706 shares of Common Stock held by Venrock Partners, and 44,176 shares of Common Stock held by Venrock Entrepreneurs. VM4, VPM and VEFM4 disclaim beneficial ownership over all shares held by Venrock IV, Venrock Partners and Venrock Entrepreneurs, except to the extent of their indirect pecuniary interests therein. Read SEC document |
| November 02, 2016 Filed Nov 4, 2016 19:57 UTC | ON Semiconductor Connectivity Solutions, Inc. QTNA · Entity 156540 | ConversionCommon Stock | 805,625 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001209191-16-148511 · doc4.xml · nonDerivative · entry 4 VENROCK ASSOCIATES IV L P · CIK 0001277997 · 10% owner Venrock Partners, L.P. · CIK 0001305239 · 10% owner VENROCK ENTREPRENEURS FUND IV L P · CIK 0001277994 · 10% owner Venrock Management IV, LLC · CIK 0001305238 · 10% owner Venrock Partners Management, LLC · CIK 0001305240 · 10% owner VEF Management IV, LLC · CIK 0001305243 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · See footnote Disclosed balance after: 1,739,305 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: The Series A Preferred Stock automatically converted into Common Stock on a 1.8868501529052:1 basis immediately prior to the closing of the Issuer's initial public offering and had no expiration date. F2 · price: The Series B Preferred Stock automatically converted into Common Stock on a 1.9332015399022:1 basis immediately prior to the closing of the Issuer's initial public offering and had no expiration date. F3 · price: The Series C Preferred Stock automatically converted into Common Stock on a 1.97882655585238:1 basis immediately prior to the closing of the Issuer's initial public offering and had no expiration date. F4 · price: The Series D Preferred Stock automatically converted into Common Stock on a 1:1 basis immediately prior to the closing of the Issuer's initial public offering and had no expiration date. F5 · price: The Series E Preferred Stock automatically converted into Common Stock on a 1:1 basis immediately prior to the closing of the Issuer's initial public offering and had no expiration date. F6 · price: The Series F-1 Preferred Stock automatically converted into Common Stock on a 1:1 basis immediately prior to the closing of the Issuer's initial public offering and had no expiration date. F7 · price: The Series G Preferred Stock automatically converted into Common Stock on a 1:1 basis immediately prior to the closing of the Issuer's initial public offering and had no expiration date. F11 · ownership.nature: Consists of an aggregate of 1,415,801 shares of Common Stock held by Venrock IV, 288,723 shares of Common Stock held by Venrock Partners, and 34,781 shares of Common Stock held by Venrock Entrepreneurs. VM4, VPM and VEFM4 disclaim beneficial ownership over all shares held by Venrock IV, Venrock Partners and Venrock Entrepreneurs, except to the extent of their indirect pecuniary interests therein. Read SEC document |
| November 02, 2016 Filed Nov 4, 2016 19:57 UTC | ON Semiconductor Connectivity Solutions, Inc. QTNA · Entity 156540 | ConversionCommon Stock | 186,644 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001209191-16-148511 · doc4.xml · nonDerivative · entry 3 VENROCK ASSOCIATES IV L P · CIK 0001277997 · 10% owner Venrock Partners, L.P. · CIK 0001305239 · 10% owner VENROCK ENTREPRENEURS FUND IV L P · CIK 0001277994 · 10% owner Venrock Management IV, LLC · CIK 0001305238 · 10% owner Venrock Partners Management, LLC · CIK 0001305240 · 10% owner VEF Management IV, LLC · CIK 0001305243 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · See footnote Disclosed balance after: 933,680 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: The Series A Preferred Stock automatically converted into Common Stock on a 1.8868501529052:1 basis immediately prior to the closing of the Issuer's initial public offering and had no expiration date. F2 · price: The Series B Preferred Stock automatically converted into Common Stock on a 1.9332015399022:1 basis immediately prior to the closing of the Issuer's initial public offering and had no expiration date. F3 · price: The Series C Preferred Stock automatically converted into Common Stock on a 1.97882655585238:1 basis immediately prior to the closing of the Issuer's initial public offering and had no expiration date. F4 · price: The Series D Preferred Stock automatically converted into Common Stock on a 1:1 basis immediately prior to the closing of the Issuer's initial public offering and had no expiration date. F5 · price: The Series E Preferred Stock automatically converted into Common Stock on a 1:1 basis immediately prior to the closing of the Issuer's initial public offering and had no expiration date. F6 · price: The Series F-1 Preferred Stock automatically converted into Common Stock on a 1:1 basis immediately prior to the closing of the Issuer's initial public offering and had no expiration date. F7 · price: The Series G Preferred Stock automatically converted into Common Stock on a 1:1 basis immediately prior to the closing of the Issuer's initial public offering and had no expiration date. F10 · ownership.nature: Consists of an aggregate of 760,021 shares of Common Stock held by Venrock IV, 154,989 shares of Common Stock held by Venrock Partners, and 18,670 shares of Common Stock held by Venrock Entrepreneurs. VM4, VPM and VEFM4 disclaim beneficial ownership over all shares held by Venrock IV, Venrock Partners and Venrock Entrepreneurs, except to the extent of their indirect pecuniary interests therein. Read SEC document |
| November 02, 2016 Filed Nov 4, 2016 19:57 UTC | ON Semiconductor Connectivity Solutions, Inc. QTNA · Entity 156540 | ConversionCommon Stock | 138,696 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001209191-16-148511 · doc4.xml · nonDerivative · entry 2 VENROCK ASSOCIATES IV L P · CIK 0001277997 · 10% owner Venrock Partners, L.P. · CIK 0001305239 · 10% owner VENROCK ENTREPRENEURS FUND IV L P · CIK 0001277994 · 10% owner Venrock Management IV, LLC · CIK 0001305238 · 10% owner Venrock Partners Management, LLC · CIK 0001305240 · 10% owner VEF Management IV, LLC · CIK 0001305243 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · See footnote Disclosed balance after: 747,036 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: The Series A Preferred Stock automatically converted into Common Stock on a 1.8868501529052:1 basis immediately prior to the closing of the Issuer's initial public offering and had no expiration date. F2 · price: The Series B Preferred Stock automatically converted into Common Stock on a 1.9332015399022:1 basis immediately prior to the closing of the Issuer's initial public offering and had no expiration date. F3 · price: The Series C Preferred Stock automatically converted into Common Stock on a 1.97882655585238:1 basis immediately prior to the closing of the Issuer's initial public offering and had no expiration date. F4 · price: The Series D Preferred Stock automatically converted into Common Stock on a 1:1 basis immediately prior to the closing of the Issuer's initial public offering and had no expiration date. F5 · price: The Series E Preferred Stock automatically converted into Common Stock on a 1:1 basis immediately prior to the closing of the Issuer's initial public offering and had no expiration date. F6 · price: The Series F-1 Preferred Stock automatically converted into Common Stock on a 1:1 basis immediately prior to the closing of the Issuer's initial public offering and had no expiration date. F7 · price: The Series G Preferred Stock automatically converted into Common Stock on a 1:1 basis immediately prior to the closing of the Issuer's initial public offering and had no expiration date. F9 · ownership.nature: Consists of an aggregate of 608,091 shares of Common Stock held by Venrock IV, 124,007 shares of Common Stock held by Venrock Partners, and 14,938 shares of Common Stock held by Venrock Entrepreneurs. VM4, VPM and VEFM4 disclaim beneficial ownership over all shares held by Venrock IV, Venrock Partners and Venrock Entrepreneurs, except to the extent of their indirect pecuniary interests therein. Read SEC document |
| November 02, 2016 Filed Nov 4, 2016 19:57 UTC | ON Semiconductor Connectivity Solutions, Inc. QTNA · Entity 156540 | ConversionCommon Stock | 608,340 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001209191-16-148511 · doc4.xml · nonDerivative · entry 1 VENROCK ASSOCIATES IV L P · CIK 0001277997 · 10% owner Venrock Partners, L.P. · CIK 0001305239 · 10% owner VENROCK ENTREPRENEURS FUND IV L P · CIK 0001277994 · 10% owner Venrock Management IV, LLC · CIK 0001305238 · 10% owner Venrock Partners Management, LLC · CIK 0001305240 · 10% owner VEF Management IV, LLC · CIK 0001305243 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · See footnote Disclosed balance after: 608,340 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: The Series A Preferred Stock automatically converted into Common Stock on a 1.8868501529052:1 basis immediately prior to the closing of the Issuer's initial public offering and had no expiration date. F2 · price: The Series B Preferred Stock automatically converted into Common Stock on a 1.9332015399022:1 basis immediately prior to the closing of the Issuer's initial public offering and had no expiration date. F3 · price: The Series C Preferred Stock automatically converted into Common Stock on a 1.97882655585238:1 basis immediately prior to the closing of the Issuer's initial public offering and had no expiration date. F4 · price: The Series D Preferred Stock automatically converted into Common Stock on a 1:1 basis immediately prior to the closing of the Issuer's initial public offering and had no expiration date. F5 · price: The Series E Preferred Stock automatically converted into Common Stock on a 1:1 basis immediately prior to the closing of the Issuer's initial public offering and had no expiration date. F6 · price: The Series F-1 Preferred Stock automatically converted into Common Stock on a 1:1 basis immediately prior to the closing of the Issuer's initial public offering and had no expiration date. F7 · price: The Series G Preferred Stock automatically converted into Common Stock on a 1:1 basis immediately prior to the closing of the Issuer's initial public offering and had no expiration date. F8 · ownership.nature: Consists of an aggregate of 495,190 shares of Common Stock held by Venrock Associates IV, L.P. ("Venrock IV"), 100,984 shares of Common Stock held by Venrock Partners, L.P. ("Venrock Partners"), and 12,166 shares of Common Stock held by Venrock Entrepreneurs Fund IV,L.P. ("Venrock Entrepreneurs" and together with Venrock IV and Venrock Partners, the "Venrock Entities"). VM4, VPM and VEFM4 disclaim beneficial ownership over all shares held by Venrock IV, Venrock Partners and Venrock Entrepreneurs, except to the extent of their indirect pecuniary interests therein. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.